BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1433596 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(ncc2F)C#C)C(=O)N1 InChI=1S/C21H14FN5OS/c1-3-16-23-9-12(22)18(27-16)14-5-4-11-13(26-14)6-7-15-17(11)19-20(29-15)21(28)25-10(2)8-24-19/h1,4-7,9-10,24H,8H2,2H3,(H,25,28) BVVCWHNWISHTIJ-UHFFFAOYSA-N 688778 US20240190890, Compound I-1::(R)-3-(2-ethynyl-5-fluoropyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 5.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688778&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542002 504490448 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433597 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)ncc2F)C(=O)N1 InChI=1S/C21H16FN5OS/c1-3-16-23-9-12(22)18(27-16)14-5-4-11-13(26-14)6-7-15-17(11)19-20(29-15)21(28)25-10(2)8-24-19/h3-7,9-10,24H,1,8H2,2H3,(H,25,28) QNGCXKWBVKCNQC-UHFFFAOYSA-N 688779 US20240190890, Compound I-2::(R)-3-(5-fluoro-2-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 133 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688779&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542016 504490449 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433598 CCOCc1cnc(Cl)nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H20ClN5O2S/c1-3-30-10-12-9-25-22(23)28-18(12)15-5-4-13-14(27-15)6-7-16-17(13)19-20(31-16)21(29)26-11(2)8-24-19/h4-7,9,11,24H,3,8,10H2,1-2H3,(H,26,29) ZSNTXLQWXIIDPC-UHFFFAOYSA-N 688780 US20240190890, Compound I-3::(R)-3-(2-chloro-5-(ethoxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 107 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688780&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430031 504490450 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433599 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2C(F)(F)F)C(=O)N1 InChI=1S/C20H13ClF3N5OS/c1-8-6-25-16-14-9-2-3-12(15-10(20(22,23)24)7-26-19(21)29-15)28-11(9)4-5-13(14)31-17(16)18(30)27-8/h2-5,7-8,25H,6H2,1H3,(H,27,30) ORBJNMQPHINFEU-UHFFFAOYSA-N 688784 US20240190890, Compound I-4::(R)-3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1.000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688784&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430032 504490454 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433600 CCOCc1cnc(C=C)nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H23N5O2S/c1-4-19-25-11-14(12-31-5-2)21(29-19)17-7-6-15-16(28-17)8-9-18-20(15)22-23(32-18)24(30)27-13(3)10-26-22/h4,6-9,11,13,26H,1,5,10,12H2,2-3H3,(H,27,30) VAVIMUFNSVHOGU-UHFFFAOYSA-N 688785 US20240190890, Compound I-5::(R)-3-(5-(ethoxymethyl)-2-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 7.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688785&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542241 504490455 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433601 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2C)C(=O)N1 InChI=1S/C20H16ClN5OS/c1-9-7-23-20(21)26-16(9)13-4-3-11-12(25-13)5-6-14-15(11)17-18(28-14)19(27)24-10(2)8-22-17/h3-7,10,22H,8H2,1-2H3,(H,24,27) RLLWVHQKAOCCID-UHFFFAOYSA-N 688786 US20240190890, Compound I-6::(R)-3-(2-chloro-5-methylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 912 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688786&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542323 504490456 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433602 COCc1nc(Cl)cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C21H18ClN5O2S/c1-10-8-23-19-18-11-3-4-13(14-7-16(22)27-17(26-14)9-29-2)25-12(11)5-6-15(18)30-20(19)21(28)24-10/h3-7,10,23H,8-9H2,1-2H3,(H,24,28) VDTBAXTXKVTWDU-UHFFFAOYSA-N 688787 US20240190890, Compound I-7::(R)-3-(6-chloro-2-(methoxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 6.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688787&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430033 504490457 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433603 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(Cl)n2)C(=O)N1 InChI=1S/C19H14ClN5OS/c1-9-8-22-16-15-10-2-3-12(13-6-7-21-19(20)25-13)24-11(10)4-5-14(15)27-17(16)18(26)23-9/h2-7,9,22H,8H2,1H3,(H,23,26) AJQHMQBBJOGZKX-UHFFFAOYSA-N 688788 US20240190890, Compound I-8::(R)-3-(2-chloropyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 75.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688788&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542010 504490458 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433604 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2C#N)C(=O)N1 InChI=1S/C20H13ClN6OS/c1-9-7-23-17-15-11-2-3-13(16-10(6-22)8-24-20(21)27-16)26-12(11)4-5-14(15)29-18(17)19(28)25-9/h2-5,8-9,23H,7H2,1H3,(H,25,28) ODYRRJORIFCZRP-UHFFFAOYSA-N 688789 US20240190890, Compound I-9::(R)-2-chloro-4-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)pyrimidine-5-carbonitrile MAP kinase-activated protein kinase 2 Homo sapiens 97.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688789&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430034 504490459 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433605 COc1cnc(Cl)nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C20H16ClN5O2S/c1-9-7-22-17-15-10-3-4-12(16-13(28-2)8-23-20(21)26-16)25-11(10)5-6-14(15)29-18(17)19(27)24-9/h3-6,8-9,22H,7H2,1-2H3,(H,24,27) NITYTAXELHCBKZ-UHFFFAOYSA-N 688790 US20240190890, Compound I-10::(R)-3-(2-chloro-5-methoxypyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 291 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688790&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542318 504490460 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433606 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)ncn2)C(=O)N1 InChI=1S/C19H14ClN5OS/c1-9-7-21-17-16-10-2-3-12(13-6-15(20)23-8-22-13)25-11(10)4-5-14(16)27-18(17)19(26)24-9/h2-6,8-9,21H,7H2,1H3,(H,24,26) SIONEJSINFOYIC-UHFFFAOYSA-N 688791 US20240190890, Compound I-11::(R)-3-(6-chloropyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688791&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541923 504490461 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433607 CCOCc1cnc(nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C#C InChI=1S/C24H21N5O2S/c1-4-19-25-11-14(12-31-5-2)21(29-19)17-7-6-15-16(28-17)8-9-18-20(15)22-23(32-18)24(30)27-13(3)10-26-22/h1,6-9,11,13,26H,5,10,12H2,2-3H3,(H,27,30) YTBUHAXTIXYOFM-UHFFFAOYSA-N 688792 US20240190890, Compound I-12::(R)-3-(5-(ethoxymethyl)-2-ethynylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 87.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688792&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430035 504490462 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433608 COCc1nc(C=C)cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C23H21N5O2S/c1-4-13-9-17(28-19(26-13)11-30-3)16-6-5-14-15(27-16)7-8-18-20(14)21-22(31-18)23(29)25-12(2)10-24-21/h4-9,12,24H,1,10-11H2,2-3H3,(H,25,29) DKNMNBDBXUQROL-UHFFFAOYSA-N 688793 US20240190890, Compound I-13::(R)-3-(2-(methoxymethyl)-6-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1.000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688793&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430036 504490463 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433609 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(COC3CCNCC3)n2)C(=O)N1 InChI=1S/C25H25ClN6O2S/c1-13-11-28-23-22-15-2-3-17(30-16(15)4-5-19(22)35-24(23)25(33)29-13)18-10-20(26)32-21(31-18)12-34-14-6-8-27-9-7-14/h2-5,10,13-14,27-28H,6-9,11-12H2,1H3,(H,29,33) KCZXCVBFVIKSNN-UHFFFAOYSA-N 688794 US20240190890, Compound I-14::(R)-3-(6-chloro-2-((piperidin-4-yloxy)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 12.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688794&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430037 504490464 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433610 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(COC3CCN(C)CC3)n2)C(=O)N1 InChI=1S/C26H27ClN6O2S/c1-14-12-28-24-23-16-3-4-18(30-17(16)5-6-20(23)36-25(24)26(34)29-14)19-11-21(27)32-22(31-19)13-35-15-7-9-33(2)10-8-15/h3-6,11,14-15,28H,7-10,12-13H2,1-2H3,(H,29,34) PLYOAEKORXFQFI-UHFFFAOYSA-N 688795 US20240190890, Compound I-15::(R)-3-(6-chloro-2-(((1-methylpiperidin-4-yl)oxy)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 10.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688795&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430038 504490465 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433611 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(Cl)n2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C24H24ClN7OS/c1-13-12-26-21-20-14-3-4-16(28-15(14)5-6-18(20)34-22(21)23(33)27-13)17-11-19(30-24(25)29-17)32-9-7-31(2)8-10-32/h3-6,11,13,26H,7-10,12H2,1-2H3,(H,27,33) RIMMRMIETFRGAU-UHFFFAOYSA-N 688796 US20240190890, Compound I-16::(R)-3-(2-chloro-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 26.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688796&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542278 504490466 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433612 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(n2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C24H24ClN7OS/c1-13-12-26-21-20-14-3-4-16(28-15(14)5-6-18(20)34-22(21)23(33)27-13)17-11-19(25)30-24(29-17)32-9-7-31(2)8-10-32/h3-6,11,13,26H,7-10,12H2,1-2H3,(H,27,33) DBYWIAYZCSBVGD-UHFFFAOYSA-N 688797 US20240190890, Compound I-17::(R)-3-(6-chloro-2-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 137 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688797&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541927 504490467 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433613 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(C=C)n2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C26H27N7OS/c1-4-21-30-19(13-22(31-21)33-11-9-32(3)10-12-33)18-6-5-16-17(29-18)7-8-20-23(16)24-25(35-20)26(34)28-15(2)14-27-24/h4-8,13,15,27H,1,9-12,14H2,2-3H3,(H,28,34) LIRATNHHKKVTIV-UHFFFAOYSA-N 688798 US20240190890, Compound I-18::(R)-10-methyl-3-(6-(4-methylpiperazin-1-yl)-2-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688798&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430039 504490468 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433614 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(n2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C26H27N7OS/c1-4-16-13-20(31-26(29-16)33-11-9-32(3)10-12-33)19-6-5-17-18(30-19)7-8-21-22(17)23-24(35-21)25(34)28-15(2)14-27-23/h4-8,13,15,27H,1,9-12,14H2,2-3H3,(H,28,34) MULTUWLZQOORFJ-UHFFFAOYSA-N 688799 US20240190890, Compound I-19::(R)-10-methyl-3-(2-(4-methylpiperazin-1-yl)-6-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688799&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430040 504490469 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433615 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2COC2COC2)C(=O)N1 InChI=1S/C23H20ClN5O3S/c1-11-6-25-20-18-14-2-3-16(28-15(14)4-5-17(18)33-21(20)22(30)27-11)19-12(7-26-23(24)29-19)8-32-13-9-31-10-13/h2-5,7,11,13,25H,6,8-10H2,1H3,(H,27,30) AYQBDPLXDVKLBH-UHFFFAOYSA-N 688800 US20240190890, Compound I-20::(R)-3-(2-chloro-5-((oxetan-3-yloxy)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 224 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688800&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430041 504490470 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433616 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)ncc2COC2COC2)C(=O)N1 InChI=1S/C25H23N5O3S/c1-3-20-26-9-14(10-33-15-11-32-12-15)22(30-20)18-5-4-16-17(29-18)6-7-19-21(16)23-24(34-19)25(31)28-13(2)8-27-23/h3-7,9,13,15,27H,1,8,10-12H2,2H3,(H,28,31) DTYXWUXJUDPYLX-UHFFFAOYSA-N 688801 US20240190890, Compound I-21::(R)-10-methyl-3-(5-((oxetan-3-yloxy)methyl)-2-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 24.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688801&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430042 504490471 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433617 CCOCc1nc(C=C)cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H23N5O2S/c1-4-14-10-18(29-20(27-14)12-31-5-2)17-7-6-15-16(28-17)8-9-19-21(15)22-23(32-19)24(30)26-13(3)11-25-22/h4,6-10,13,25H,1,5,11-12H2,2-3H3,(H,26,30) SILISHPIGXVBCB-UHFFFAOYSA-N 688802 US20240190890, Compound I-22::(R)-3-(2-(ethoxymethyl)-6-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688802&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542298 504490472 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433618 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(COC3CCOCC3)n2)C(=O)N1 InChI=1S/C25H24ClN5O3S/c1-13-11-27-23-22-15-2-3-17(29-16(15)4-5-19(22)35-24(23)25(32)28-13)18-10-20(26)31-21(30-18)12-34-14-6-8-33-9-7-14/h2-5,10,13-14,27H,6-9,11-12H2,1H3,(H,28,32) SJXJFZZGSWNNSX-UHFFFAOYSA-N 688803 US20240190890, Compound I-23::(R)-3-(6-chloro-2-(((tetrahydro-2H-pyran-4-yl)oxy)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 487 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688803&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430043 504490473 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433619 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2COC2CCOCC2)C(=O)N1 InChI=1S/C25H24ClN5O3S/c1-13-10-27-22-20-16-2-3-18(30-17(16)4-5-19(20)35-23(22)24(32)29-13)21-14(11-28-25(26)31-21)12-34-15-6-8-33-9-7-15/h2-5,11,13,15,27H,6-10,12H2,1H3,(H,29,32) QTQKYZVSVALXMF-UHFFFAOYSA-N 688804 US20240190890, Compound I-24::(R)-3-(2-chloro-5-(((tetrahydro-2H-pyran-4-yl)oxy)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 98.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688804&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430044 504490474 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433620 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)ncc2COC2CCOCC2)C(=O)N1 InChI=1S/C27H27N5O3S/c1-3-22-28-13-16(14-35-17-8-10-34-11-9-17)24(32-22)20-5-4-18-19(31-20)6-7-21-23(18)25-26(36-21)27(33)30-15(2)12-29-25/h3-7,13,15,17,29H,1,8-12,14H2,2H3,(H,30,33) PMLDZZCBZCINEQ-UHFFFAOYSA-N 688805 US20240190890, Compound I-25::(R)-10-methyl-3-(5-(((tetrahydro-2H-pyran-4-yl)oxy)methyl)-2-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 43.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688805&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430045 504490475 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433621 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)ncc2COC2(C)CCC2)C(=O)N1 InChI=1S/C27H27N5O2S/c1-4-21-28-13-16(14-34-27(3)10-5-11-27)23(32-21)19-7-6-17-18(31-19)8-9-20-22(17)24-25(35-20)26(33)30-15(2)12-29-24/h4,6-9,13,15,29H,1,5,10-12,14H2,2-3H3,(H,30,33) KIQYISYRKZTJRF-UHFFFAOYSA-N 688806 US20240190890, Compound I-26::(R)-10-methyl-3-(5-((1-methylcyclobutoxy)methyl)-2-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 684 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688806&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430046 504490476 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433622 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2COC2(C)CCC2)C(=O)N1 InChI=1S/C25H24ClN5O2S/c1-13-10-27-21-19-15-4-5-17(30-16(15)6-7-18(19)34-22(21)23(32)29-13)20-14(11-28-24(26)31-20)12-33-25(2)8-3-9-25/h4-7,11,13,27H,3,8-10,12H2,1-2H3,(H,29,32) UOSJXQVWMSVZFT-UHFFFAOYSA-N 688807 US20240190890, Compound I-27::(R)-3-(2-chloro-5-((1-methylcyclobutoxy)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 391 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688807&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430047 504490477 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433623 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2COC2(C)COC2)C(=O)N1 InChI=1S/C24H22ClN5O3S/c1-12-7-26-20-18-14-3-4-16(29-15(14)5-6-17(18)34-21(20)22(31)28-12)19-13(8-27-23(25)30-19)9-33-24(2)10-32-11-24/h3-6,8,12,26H,7,9-11H2,1-2H3,(H,28,31) GUJCSSPNTAFYOP-UHFFFAOYSA-N 688808 US20240190890, Compound I-28::(R)-3-(2-chloro-5-(((3-methyloxetan-3-yl)oxy)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 18.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688808&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430048 504490478 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433624 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)ncc2COC2(C)COC2)C(=O)N1 InChI=1S/C26H25N5O3S/c1-4-20-27-10-15(11-34-26(3)12-33-13-26)22(31-20)18-6-5-16-17(30-18)7-8-19-21(16)23-24(35-19)25(32)29-14(2)9-28-23/h4-8,10,14,28H,1,9,11-13H2,2-3H3,(H,29,32) LEQJYFUUAIXVFI-UHFFFAOYSA-N 688809 US20240190890, Compound I-29::(R)-10-methyl-3-(5-(((3-methyloxetan-3-yl)oxy)methyl)-2-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 20.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688809&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430049 504490479 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433625 CCOCc1nc(Cl)cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H20ClN5O2S/c1-3-30-10-18-27-15(8-17(23)28-18)14-5-4-12-13(26-14)6-7-16-19(12)20-21(31-16)22(29)25-11(2)9-24-20/h4-8,11,24H,3,9-10H2,1-2H3,(H,25,29) DDYIJJDQUHFVDK-UHFFFAOYSA-N 688810 US20240190890, Compound I-30::(R)-3-(6-chloro-2-(ethoxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 16.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688810&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430050 504490480 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433626 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(ncc2F)C(F)=C)C(=O)N1 InChI=1S/C21H15F2N5OS/c1-9-7-24-18-16-11-3-4-14(17-12(23)8-25-20(28-17)10(2)22)27-13(11)5-6-15(16)30-19(18)21(29)26-9/h3-6,8-9,24H,2,7H2,1H3,(H,26,29) AIORCMBYICBIPW-UHFFFAOYSA-N 688811 US20240190890, Compound I-31::(R)-3-(5-fluoro-2-(1-fluorovinyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 24.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688811 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688811&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542372 504490481 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433627 COc1cnc(C=C)nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H19N5O2S/c1-4-17-23-10-15(29-3)19(27-17)14-6-5-12-13(26-14)7-8-16-18(12)20-21(30-16)22(28)25-11(2)9-24-20/h4-8,10-11,24H,1,9H2,2-3H3,(H,25,28) ZSNFZBZFZAUJRD-UHFFFAOYSA-N 688812 US20240190890, Compound I-32::(R)-3-(5-methoxy-2-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 245 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688812&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541942 504490482 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433628 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)ncc2C)C(=O)N1 InChI=1S/C22H19N5OS/c1-4-17-23-9-11(2)19(27-17)15-6-5-13-14(26-15)7-8-16-18(13)20-21(29-16)22(28)25-12(3)10-24-20/h4-9,12,24H,1,10H2,2-3H3,(H,25,28) RAWKURMVCZTJOF-UHFFFAOYSA-N 688813 US20240190890, Compound I-33::(R)-10-methyl-3-(5-methyl-2-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 120 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688813&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542187 504490483 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433629 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncn2)C(=O)N1 InChI=1S/C21H17N5OS/c1-3-12-8-16(24-10-23-12)15-5-4-13-14(26-15)6-7-17-18(13)19-20(28-17)21(27)25-11(2)9-22-19/h3-8,10-11,22H,1,9H2,2H3,(H,25,27) JOGRWPGDQIWXTF-UHFFFAOYSA-N 688814 US20240190890, Compound I-34::(R)-10-methyl-3-(6-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688814&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542249 504490484 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433630 CCOCc1nc(\C=C\C)cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C25H25N5O2S/c1-4-6-15-11-19(30-21(28-15)13-32-5-2)18-8-7-16-17(29-18)9-10-20-22(16)23-24(33-20)25(31)27-14(3)12-26-23/h4,6-11,14,26H,5,12-13H2,1-3H3,(H,27,31) YVIHCSPDXLEDAA-UHFFFAOYSA-N 688815 US20240190890, Compound I-35::(R,E)-3-(2-(ethoxymethyl)-6-(prop-1-en-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 40.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688815&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430051 504490485 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433631 CCOCc1nc(\C=C/C)cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C25H25N5O2S/c1-4-6-15-11-19(30-21(28-15)13-32-5-2)18-8-7-16-17(29-18)9-10-20-22(16)23-24(33-20)25(31)27-14(3)12-26-23/h4,6-11,14,26H,5,12-13H2,1-3H3,(H,27,31) YVIHCSPDXLEDAA-UHFFFAOYSA-N 688816 US20240190890, Compound I-36::(R,Z)-3-(2-(ethoxymethyl)-6-(prop-1-en-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 12.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688816&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430052 504490486 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433632 CCOCc1nc(cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C(C)=C InChI=1S/C25H25N5O2S/c1-5-32-12-21-29-18(13(2)3)10-19(30-21)17-7-6-15-16(28-17)8-9-20-22(15)23-24(33-20)25(31)27-14(4)11-26-23/h6-10,14,26H,2,5,11-12H2,1,3-4H3,(H,27,31) BIVOXTKEWOGODP-UHFFFAOYSA-N 688817 US20240190890, Compound I-37::(R)-3-(2-(ethoxymethyl)-6-(prop-1-en-2-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 10.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688817&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430053 504490487 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433633 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncn2)C#C)C(=O)N1 InChI=1S/C21H15N5OS/c1-3-12-8-16(24-10-23-12)15-5-4-13-14(26-15)6-7-17-18(13)19-20(28-17)21(27)25-11(2)9-22-19/h1,4-8,10-11,22H,9H2,2H3,(H,25,27) KICRPFCNWPLNPV-UHFFFAOYSA-N 688818 US20240190890, Compound I-38::(R)-3-(6-ethynylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 5.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688818&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542115 504490488 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433634 CCOCc1nc(cc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C#C InChI=1S/C24H21N5O2S/c1-4-14-10-18(29-20(27-14)12-31-5-2)17-7-6-15-16(28-17)8-9-19-21(15)22-23(32-19)24(30)26-13(3)11-25-22/h1,6-10,13,25H,5,11-12H2,2-3H3,(H,26,30) MPFLTQYLTCEPKM-UHFFFAOYSA-N 688819 US20240190890, Compound I-39::(R)-3-(2-(ethoxymethyl)-6-ethynylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 8.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688819&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430054 504490489 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433635 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(n2)C#C)C(=O)N1 InChI=1S/C21H15N5OS/c1-3-17-22-9-8-15(26-17)14-5-4-12-13(25-14)6-7-16-18(12)19-20(28-16)21(27)24-11(2)10-23-19/h1,4-9,11,23H,10H2,2H3,(H,24,27) XUNBSQBNWUKIOH-UHFFFAOYSA-N 688820 US20240190890, Compound I-40::(R)-3-(2-ethynylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 25.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688820&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542221 504490490 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433636 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(ncc2C)C#C)C(=O)N1 InChI=1S/C22H17N5OS/c1-4-17-23-9-11(2)19(27-17)15-6-5-13-14(26-15)7-8-16-18(13)20-21(29-16)22(28)25-12(3)10-24-20/h1,5-9,12,24H,10H2,2-3H3,(H,25,28) XRYIJBLDIZNAOU-UHFFFAOYSA-N 688821 US20240190890, Compound I-41::(R)-3-(2-ethynyl-5-methylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 199 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688821&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541919 504490491 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433637 COc1cnc(nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C#C InChI=1S/C22H17N5O2S/c1-4-17-23-10-15(29-3)19(27-17)14-6-5-12-13(26-14)7-8-16-18(12)20-21(30-16)22(28)25-11(2)9-24-20/h1,5-8,10-11,24H,9H2,2-3H3,(H,25,28) XFQSIHBBSVWUHX-UHFFFAOYSA-N 688822 US20240190890, Compound I-42::(R)-3-(2-ethynyl-5-methoxypyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 233 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688822&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542104 504490492 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433638 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)cc(n2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C24H24ClN7OS/c1-13-12-26-21-20-14-3-4-16(28-15(14)5-6-17(20)34-22(21)24(33)27-13)23-29-18(25)11-19(30-23)32-9-7-31(2)8-10-32/h3-6,11,13,26H,7-10,12H2,1-2H3,(H,27,33) BWNDEJUMHXPHMS-UHFFFAOYSA-N 688823 US20240190890, Compound I-43::(R)-3-(4-chloro-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 440 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688823&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541996 504490493 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433639 CC#Cc1ncc(F)c(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H16FN5OS/c1-3-4-17-24-10-13(23)19(28-17)15-6-5-12-14(27-15)7-8-16-18(12)20-21(30-16)22(29)26-11(2)9-25-20/h5-8,10-11,25H,9H2,1-2H3,(H,26,29) XLHGCCPGQZNFQM-UHFFFAOYSA-N 688824 US20240190890, Compound I-44::(R)-3-(5-fluoro-2-(prop-1-yn-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688824&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430055 504490494 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433640 C\C=C\c1ncc(F)c(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H18FN5OS/c1-3-4-17-24-10-13(23)19(28-17)15-6-5-12-14(27-15)7-8-16-18(12)20-21(30-16)22(29)26-11(2)9-25-20/h3-8,10-11,25H,9H2,1-2H3,(H,26,29) FLNIFDUJLFXYGW-UHFFFAOYSA-N 688825 US20240190890, Compound I-45::(R,E)-3-(5-fluoro-2-(prop-1-en-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 160 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688825&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430056 504490495 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433641 C\C=C/c1ncc(F)c(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H18FN5OS/c1-3-4-17-24-10-13(23)19(28-17)15-6-5-12-14(27-15)7-8-16-18(12)20-21(30-16)22(29)26-11(2)9-25-20/h3-8,10-11,25H,9H2,1-2H3,(H,26,29) FLNIFDUJLFXYGW-UHFFFAOYSA-N 688826 US20240190890, Compound I-46::(R,Z)-3-(5-fluoro-2-(prop-1-en-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 765 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688826 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688826&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430057 504490496 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433642 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(ncc2F)C(C)=C)C(=O)N1 InChI=1S/C22H18FN5OS/c1-10(2)21-25-9-13(23)18(28-21)15-5-4-12-14(27-15)6-7-16-17(12)19-20(30-16)22(29)26-11(3)8-24-19/h4-7,9,11,24H,1,8H2,2-3H3,(H,26,29) VHRFDKQHROTPCY-UHFFFAOYSA-N 688827 US20240190890, Compound I-47::(R)-3-(5-fluoro-2-(prop-1-en-2-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 429 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688827 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688827&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430058 504490497 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433643 CCOCc1cnc(\C=C\C)nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C25H25N5O2S/c1-4-6-20-26-12-15(13-32-5-2)22(30-20)18-8-7-16-17(29-18)9-10-19-21(16)23-24(33-19)25(31)28-14(3)11-27-23/h4,6-10,12,14,27H,5,11,13H2,1-3H3,(H,28,31) DQBHCTFMVKFFLY-UHFFFAOYSA-N 688828 US20240190890, Compound I-48::(R,E)-3-(5-(ethoxymethyl)-2-(prop-1-en-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 371 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688828 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688828&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430059 504490498 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433644 CCOCc1cnc(\C=C/C)nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C25H25N5O2S/c1-4-6-20-26-12-15(13-32-5-2)22(30-20)18-8-7-16-17(29-18)9-10-19-21(16)23-24(33-19)25(31)28-14(3)11-27-23/h4,6-10,12,14,27H,5,11,13H2,1-3H3,(H,28,31) DQBHCTFMVKFFLY-UHFFFAOYSA-N 688829 US20240190890, Compound I-49::(R,Z)-3-(5-(ethoxymethyl)-2-(prop-1-en-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 474 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688829 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688829&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430060 504490499 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433645 CCOCc1cnc(nc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C(C)=C InChI=1S/C25H25N5O2S/c1-5-32-12-15-11-27-24(13(2)3)30-21(15)18-7-6-16-17(29-18)8-9-19-20(16)22-23(33-19)25(31)28-14(4)10-26-22/h6-9,11,14,26H,2,5,10,12H2,1,3-4H3,(H,28,31) MVGUVPJNHMGYPJ-UHFFFAOYSA-N 688830 US20240190890, Compound I-50::(R)-3-(5-(ethoxymethyl)-2-(prop-1-en-2-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688830 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688830&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430061 504490500 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433646 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cnnc(c2)C#C)C(=O)N1 InChI=1S/C21H15N5OS/c1-3-13-8-12(10-23-26-13)15-5-4-14-16(25-15)6-7-17-18(14)19-20(28-17)21(27)24-11(2)9-22-19/h1,4-8,10-11,22H,9H2,2H3,(H,24,27) BVBXVSHVIMXLMZ-UHFFFAOYSA-N 688831 US20240190890, Compound I-51::(R)-3-(6-ethynylpyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 3.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688831 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688831&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541965 504490501 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433647 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cccc(Cl)n2)C(=O)N1 InChI=1S/C20H15ClN4OS/c1-10-9-22-18-17-11-5-6-14(13-3-2-4-16(21)25-13)24-12(11)7-8-15(17)27-19(18)20(26)23-10/h2-8,10,22H,9H2,1H3,(H,23,26) USFZWJWCDFAMEY-UHFFFAOYSA-N 688832 US20240190890, Compound I-52::(R)-3-(6-chloropyridin-2-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 116 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688832 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688832&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542211 504490502 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433648 CC#Cc1nccc(n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H17N5OS/c1-3-4-18-23-10-9-16(27-18)15-6-5-13-14(26-15)7-8-17-19(13)20-21(29-17)22(28)25-12(2)11-24-20/h5-10,12,24H,11H2,1-2H3,(H,25,28) NUQBINNJLBLWCE-UHFFFAOYSA-N 688833 US20240190890, Compound I-53::(R)-10-methyl-3-(2-(prop-1-yn-1-yl)pyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 213 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688833 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688833&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542063 504490503 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433649 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cccc(C=C)n2)C(=O)N1 InChI=1S/C22H18N4OS/c1-3-13-5-4-6-16(25-13)17-8-7-14-15(26-17)9-10-18-19(14)20-21(28-18)22(27)24-12(2)11-23-20/h3-10,12,23H,1,11H2,2H3,(H,24,27) OHCFGXSCVPFNGX-UHFFFAOYSA-N 688834 US20240190890, Compound I-54::(R)-10-methyl-3-(6-vinylpyridin-2-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 61.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688834 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688834&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541935 504490504 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433650 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(C=C)c2)C(=O)N1 InChI=1S/C22H18N4OS/c1-3-14-10-13(8-9-23-14)16-5-4-15-17(26-16)6-7-18-19(15)20-21(28-18)22(27)25-12(2)11-24-20/h3-10,12,24H,1,11H2,2H3,(H,25,27) MYNYYKUDCHZRNE-UHFFFAOYSA-N 688835 US20240190890, Compound I-55::(R)-10-methyl-3-(2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1.000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688835&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542200 504490505 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433651 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cccc(n2)C#C)C(=O)N1 InChI=1S/C22H16N4OS/c1-3-13-5-4-6-16(25-13)17-8-7-14-15(26-17)9-10-18-19(14)20-21(28-18)22(27)24-12(2)11-23-20/h1,4-10,12,23H,11H2,2H3,(H,24,27) PNBFNBZSDRFBDS-UHFFFAOYSA-N 688836 US20240190890, Compound I-56::(R)-3-(6-ethynylpyridin-2-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 194 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688836 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688836&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542041 504490506 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433652 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(c2)C#C)C(=O)N1 InChI=1S/C22H16N4OS/c1-3-14-10-13(8-9-23-14)16-5-4-15-17(26-16)6-7-18-19(15)20-21(28-18)22(27)25-12(2)11-24-20/h1,4-10,12,24H,11H2,2H3,(H,25,27) JWDHKFRHTPOZEQ-UHFFFAOYSA-N 688837 US20240190890, Compound I-57::(R)-3-(2-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 117 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688837 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688837&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542335 504490507 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433653 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(Cl)n2)C(=O)N1 InChI=1S/C19H13Cl2N5OS/c1-8-7-22-16-15-9-2-3-11(12-6-14(20)26-19(21)25-12)24-10(9)4-5-13(15)28-17(16)18(27)23-8/h2-6,8,22H,7H2,1H3,(H,23,27) MKWSHKGKZOOOJG-UHFFFAOYSA-N 688838 US20240190890, Compound I-58::(R)-3-(2,6-dichloropyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 16.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688838 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688838&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542089 504490508 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433654 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(n2)N2CCN(C)CC2)C#C)C(=O)N1 InChI=1S/C26H25N7OS/c1-4-16-13-20(31-26(29-16)33-11-9-32(3)10-12-33)19-6-5-17-18(30-19)7-8-21-22(17)23-24(35-21)25(34)28-15(2)14-27-23/h1,5-8,13,15,27H,9-12,14H2,2-3H3,(H,28,34) KQFCYNIFDYXONJ-UHFFFAOYSA-N 688839 US20240190890, Compound I-59::(R)-3-(6-ethynyl-2-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 3.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688839 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688839&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541894 504490509 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433655 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(n2)C#C)N2CCN(C)CC2)C(=O)N1 InChI=1S/C26H25N7OS/c1-4-21-30-19(13-22(31-21)33-11-9-32(3)10-12-33)18-6-5-16-17(29-18)7-8-20-23(16)24-25(35-20)26(34)28-15(2)14-27-24/h1,5-8,13,15,27H,9-12,14H2,2-3H3,(H,28,34) SMBZDMXJIVBQRD-UHFFFAOYSA-N 688840 US20240190890, Compound I-60::(R)-3-(2-ethynyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 58.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688840 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688840&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542367 504490510 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433656 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(cc(n2)N2CCN(C)CC2)C#C)C(=O)N1 InChI=1S/C26H25N7OS/c1-4-16-13-21(33-11-9-32(3)10-12-33)31-25(29-16)19-6-5-17-18(30-19)7-8-20-22(17)23-24(35-20)26(34)28-15(2)14-27-23/h1,5-8,13,15,27H,9-12,14H2,2-3H3,(H,28,34) SDTWKSUZEDOUTH-UHFFFAOYSA-N 688841 US20240190890, Compound I-61::(R)-3-(4-ethynyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 73.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688841 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688841&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541981 504490511 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433657 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)cc(n2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C26H27N7OS/c1-4-16-13-21(33-11-9-32(3)10-12-33)31-25(29-16)19-6-5-17-18(30-19)7-8-20-22(17)23-24(35-20)26(34)28-15(2)14-27-23/h4-8,13,15,27H,1,9-12,14H2,2-3H3,(H,28,34) KJIOXAVMHVNNKF-UHFFFAOYSA-N 688842 US20240190890, Compound I-62::(R)-10-methyl-3-(4-(4-methylpiperazin-1-yl)-6-vinylpyrimidin-2-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 27.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688842 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688842&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541921 504490512 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433658 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(Cl)n2)C#CC(C)(C)N)C(=O)N1 InChI=1S/C24H21ClN6OS/c1-12-11-27-20-19-14-4-5-16(17-10-13(29-23(25)31-17)8-9-24(2,3)26)30-15(14)6-7-18(19)33-21(20)22(32)28-12/h4-7,10,12,27H,11,26H2,1-3H3,(H,28,32) FSRYAVYJLZEZID-UHFFFAOYSA-N 688843 US20240190890, Compound I-63::(R)-3-(6-(3-amino-3-methylbut-1-yn-1-yl)-2-chloropyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 145 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688843 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688843&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542380 504490513 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433659 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(n2)C#CC(C)(C)N)C(=O)N1 InChI=1S/C24H21ClN6OS/c1-12-11-27-21-20-13-4-5-15(16-10-18(25)31-19(30-16)8-9-24(2,3)26)29-14(13)6-7-17(20)33-22(21)23(32)28-12/h4-7,10,12,27H,11,26H2,1-3H3,(H,28,32) YETBMUOJAIZBLY-UHFFFAOYSA-N 688844 US20240190890, Compound I-64::(R)-3-(2-(3-amino-3-methylbut-1-yn-1-yl)-6-chloropyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688844 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688844&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541889 504490514 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433660 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(n2)C#C)C#CC(C)(C)N)C(=O)N1 InChI=1S/C26H22N6OS/c1-5-21-30-15(10-11-26(3,4)27)12-19(32-21)18-7-6-16-17(31-18)8-9-20-22(16)23-24(34-20)25(33)29-14(2)13-28-23/h1,6-9,12,14,28H,13,27H2,2-4H3,(H,29,33) XFEZDBSDHKHXRV-UHFFFAOYSA-N 688845 US20240190890, Compound I-65::(R)-3-(6-(3-amino-3-methylbut-1-yn-1-yl)-2-ethynylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 132 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688845 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688845&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542057 504490515 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433661 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(n2)C#CC(C)(C)N)C(=O)N1 InChI=1S/C26H24N6OS/c1-5-15-12-19(32-21(30-15)10-11-26(3,4)27)18-7-6-16-17(31-18)8-9-20-22(16)23-24(34-20)25(33)29-14(2)13-28-23/h5-9,12,14,28H,1,13,27H2,2-4H3,(H,29,33) HBSWQVAYBXTFRM-UHFFFAOYSA-N 688846 US20240190890, Compound I-66::(R)-3-(2-(3-amino-3-methylbut-1-yn-1-yl)-6-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 9.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688846&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542356 504490516 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433662 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(n2)C#CC(C)(C)N)C#C)C(=O)N1 InChI=1S/C26H22N6OS/c1-5-15-12-19(32-21(30-15)10-11-26(3,4)27)18-7-6-16-17(31-18)8-9-20-22(16)23-24(34-20)25(33)29-14(2)13-28-23/h1,6-9,12,14,28H,13,27H2,2-4H3,(H,29,33) FACXTMRYVBCUSA-UHFFFAOYSA-N 688847 US20240190890, Compound I-67::(R)-3-(2-(3-amino-3-methylbut-1-yn-1-yl)-6-ethynylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 38.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688847&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542090 504490517 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433663 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(Cl)c2)C(=O)N1 InChI=1S/C20H14Cl2N4OS/c1-9-8-23-18-17-11-2-3-12(10-6-15(21)26-16(22)7-10)25-13(11)4-5-14(17)28-19(18)20(27)24-9/h2-7,9,23H,8H2,1H3,(H,24,27) OMVLFGQFIWVUHE-UHFFFAOYSA-N 688848 US20240190890, Compound I-68::(R)-3-(2,6-dichloropyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 472 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688848 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688848&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541904 504490518 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433664 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)ncc2F)C(=O)N1 InChI=1S/C20H14ClFN4OS/c1-9-7-24-18-17-10-2-3-14(11-6-16(21)23-8-12(11)22)26-13(10)4-5-15(17)28-19(18)20(27)25-9/h2-6,8-9,24H,7H2,1H3,(H,25,27) QNARWVANLCWUGN-UHFFFAOYSA-N 688849 US20240190890, Compound I-69::(R)-3-(2-chloro-5-fluoropyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 27.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688849 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688849&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541917 504490519 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433665 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2F)C(=O)N1 InChI=1S/C22H17FN4OS/c1-3-12-8-14(15(23)10-24-12)17-5-4-13-16(27-17)6-7-18-19(13)20-21(29-18)22(28)26-11(2)9-25-20/h3-8,10-11,25H,1,9H2,2H3,(H,26,28) XYOHFBMGNDCRQP-UHFFFAOYSA-N 688850 US20240190890, Compound I-70::(R)-3-(5-fluoro-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 64.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688850&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542081 504490520 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433666 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2F)C(=O)N1 InChI=1S/C22H17FN4OS/c1-3-12-8-14(15(23)10-24-12)17-5-4-13-16(27-17)6-7-18-19(13)20-21(29-18)22(28)26-11(2)9-25-20/h3-8,10-11,25H,1,9H2,2H3,(H,26,28) XYOHFBMGNDCRQP-UHFFFAOYSA-N 688850 US20240190890, Compound I-70::(R)-3-(5-fluoro-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 64.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688850&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542081 504490520 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433667 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncc2F)C#C)C(=O)N1 InChI=1S/C22H15FN4OS/c1-3-12-8-14(15(23)10-24-12)17-5-4-13-16(27-17)6-7-18-19(13)20-21(29-18)22(28)26-11(2)9-25-20/h1,4-8,10-11,25H,9H2,2H3,(H,26,28) WKWBAHVAISIMRG-UHFFFAOYSA-N 688851 US20240190890, Compound I-71::(R)-3-(2-ethynyl-5-fluoropyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 39.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688851 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688851&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542265 504490521 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433668 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(C=C)c2)C(=O)N1 InChI=1S/C22H17ClN4OS/c1-3-13-8-12(9-18(23)26-13)15-5-4-14-16(27-15)6-7-17-19(14)20-21(29-17)22(28)25-11(2)10-24-20/h3-9,11,24H,1,10H2,2H3,(H,25,28) IPMSWOLKTYVOQD-UHFFFAOYSA-N 688852 US20240190890, Compound I-72::(R)-3-(2-chloro-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 58.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688852 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688852&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541913 504490522 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433669 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(c2)C#C)C(=O)N1 InChI=1S/C22H15ClN4OS/c1-3-13-8-12(9-18(23)26-13)15-5-4-14-16(27-15)6-7-17-19(14)20-21(29-17)22(28)25-11(2)10-24-20/h1,4-9,11,24H,10H2,2H3,(H,25,28) KNWZKFSMKARMPX-UHFFFAOYSA-N 688853 US20240190890, Compound I-73::(R)-3-(2-chloro-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 75.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688853 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688853&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542182 504490523 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433670 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(CO)n2)C(=O)N1 InChI=1S/C20H16ClN5O2S/c1-9-7-22-18-17-10-2-3-12(13-6-15(21)26-16(8-27)25-13)24-11(10)4-5-14(17)29-19(18)20(28)23-9/h2-6,9,22,27H,7-8H2,1H3,(H,23,28) YYCUVRNNEYIWTL-UHFFFAOYSA-N 688854 US20240190890, Compound I-74::(R)-3-(6-chloro-2-(hydroxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688854 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688854&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542395 504490524 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433671 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2CO)C(=O)N1 InChI=1S/C20H16ClN5O2S/c1-9-6-22-17-15-11-2-3-13(16-10(8-27)7-23-20(21)26-16)25-12(11)4-5-14(15)29-18(17)19(28)24-9/h2-5,7,9,22,27H,6,8H2,1H3,(H,24,28) MQLHTPGAZSKJLV-UHFFFAOYSA-N 688855 US20240190890, Compound I-75::(R)-3-(2-chloro-5-(hydroxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 470 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688855 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688855&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430062 504490525 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433672 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(CO)n2)C(=O)N1 InChI=1S/C22H19N5O2S/c1-3-12-8-16(27-18(10-28)25-12)15-5-4-13-14(26-15)6-7-17-19(13)20-21(30-17)22(29)24-11(2)9-23-20/h3-8,11,23,28H,1,9-10H2,2H3,(H,24,29) XMULTJFUTVJKSI-UHFFFAOYSA-N 688856 US20240190890, Compound I-76::(R)-3-(2-(hydroxymethyl)-6-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1.000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688856 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688856&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171723350 504490526 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433673 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)ncc2CO)C(=O)N1 InChI=1S/C22H19N5O2S/c1-3-17-23-9-12(10-28)19(27-17)15-5-4-13-14(26-15)6-7-16-18(13)20-21(30-16)22(29)25-11(2)8-24-20/h3-7,9,11,24,28H,1,8,10H2,2H3,(H,25,29) OVNZURBXUWSRNU-UHFFFAOYSA-N 688857 US20240190890, Compound I-77::(R)-3-(5-(hydroxymethyl)-2-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688857 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688857&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430063 504490527 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433674 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(CO)n2)C#C)C(=O)N1 InChI=1S/C22H17N5O2S/c1-3-12-8-16(27-18(10-28)25-12)15-5-4-13-14(26-15)6-7-17-19(13)20-21(30-17)22(29)24-11(2)9-23-20/h1,4-8,11,23,28H,9-10H2,2H3,(H,24,29) KWAQTRMBRFUMSW-UHFFFAOYSA-N 688858 US20240190890, Compound I-78::(R)-3-(6-ethynyl-2-(hydroxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1.000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688858 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688858&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430064 504490528 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433675 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(ncc2CO)C#C)C(=O)N1 InChI=1S/C22H17N5O2S/c1-3-17-23-9-12(10-28)19(27-17)15-5-4-13-14(26-15)6-7-16-18(13)20-21(30-16)22(29)25-11(2)8-24-20/h1,4-7,9,11,24,28H,8,10H2,2H3,(H,25,29) OMUCUAHETUELSO-UHFFFAOYSA-N 688859 US20240190890, Compound I-79::(R)-3-(2-ethynyl-5-(hydroxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 568 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688859&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430065 504490529 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433676 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(C=C)c2)C(=O)N1 InChI=1S/C24H20N4OS/c1-4-15-10-14(11-16(5-2)27-15)18-7-6-17-19(28-18)8-9-20-21(17)22-23(30-20)24(29)26-13(3)12-25-22/h4-11,13,25H,1-2,12H2,3H3,(H,26,29) LADNKUIQYTXGLE-UHFFFAOYSA-N 688860 US20240190890, Compound I-80::(R)-3-(2,6-divinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 574 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688860 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688860&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542258 504490530 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433677 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cncc(Cl)c2)C(=O)N1 InChI=1S/C20H15ClN4OS/c1-10-7-23-18-17-13-2-3-14(11-6-12(21)9-22-8-11)25-15(13)4-5-16(17)27-19(18)20(26)24-10/h2-6,8-10,23H,7H2,1H3,(H,24,26) QQTGTJWFPXQYGI-UHFFFAOYSA-N 688861 US20240190890, Compound I-81::(R)-3-(5-chloropyridin-3-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 90.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688861 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688861&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542185 504490531 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433678 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cncc(C=C)c2)C(=O)N1 InChI=1S/C22H18N4OS/c1-3-13-8-14(11-23-10-13)16-5-4-15-17(26-16)6-7-18-19(15)20-21(28-18)22(27)25-12(2)9-24-20/h3-8,10-12,24H,1,9H2,2H3,(H,25,27) KOEVHPWTIDKAJL-UHFFFAOYSA-N 688862 US20240190890, Compound I-82::(R)-10-methyl-3-(5-vinylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 21.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688862 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688862&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542075 504490532 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433679 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cncc(c2)C#C)C(=O)N1 InChI=1S/C22H16N4OS/c1-3-13-8-14(11-23-10-13)16-5-4-15-17(26-16)6-7-18-19(15)20-21(28-18)22(27)25-12(2)9-24-20/h1,4-8,10-12,24H,9H2,2H3,(H,25,27) GUHDAQXDOKYXAR-UHFFFAOYSA-N 688863 US20240190890, Compound I-83::(R)-3-(5-ethynylpyridin-3-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 83.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688863 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688863&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542389 504490533 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433680 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CO)nc(Cl)n2)C(=O)N1 InChI=1S/C20H16ClN5O2S/c1-9-7-22-17-16-11-2-3-13(14-6-10(8-27)24-20(21)26-14)25-12(11)4-5-15(16)29-18(17)19(28)23-9/h2-6,9,22,27H,7-8H2,1H3,(H,23,28) VYWUDUXGQOKZTP-UHFFFAOYSA-N 688864 US20240190890, Compound I-84::(R)-3-(2-chloro-6-(hydroxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 39.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688864 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688864&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430066 504490534 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433681 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CO)nc(C=C)n2)C(=O)N1 InChI=1S/C22H19N5O2S/c1-3-18-25-12(10-28)8-16(27-18)15-5-4-13-14(26-15)6-7-17-19(13)20-21(30-17)22(29)24-11(2)9-23-20/h3-8,11,23,28H,1,9-10H2,2H3,(H,24,29) CILBQUCMCQOTOD-UHFFFAOYSA-N 688865 US20240190890, Compound I-85::(R)-3-(6-(hydroxymethyl)-2-vinylpyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 11.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688865 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688865&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430067 504490535 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433682 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CO)nc(n2)C#C)C(=O)N1 InChI=1S/C22H17N5O2S/c1-3-18-25-12(10-28)8-16(27-18)15-5-4-13-14(26-15)6-7-17-19(13)20-21(30-17)22(29)24-11(2)9-23-20/h1,4-8,11,23,28H,9-10H2,2H3,(H,24,29) SJCFLQQWVNXDRI-UHFFFAOYSA-N 688866 US20240190890, Compound I-86::(R)-3-(2-ethynyl-6-(hydroxymethyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 23.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688866 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688866&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430068 504490536 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433683 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCN(C)CC3)nc(Cl)n2)C(=O)N1 InChI=1S/C25H26ClN7OS/c1-14-12-27-22-21-16-3-4-18(30-17(16)5-6-20(21)35-23(22)24(34)28-14)19-11-15(29-25(26)31-19)13-33-9-7-32(2)8-10-33/h3-6,11,14,27H,7-10,12-13H2,1-2H3,(H,28,34) URGLCIMOWPVOLD-UHFFFAOYSA-N 688867 US20240190890, Compound I-87::(R)-3-(2-chloro-6-((4-methylpiperazin-1-yl)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 283 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688867 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688867&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430069 504490537 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433684 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCN(C)CC3)nc(C=C)n2)C(=O)N1 InChI=1S/C27H29N7OS/c1-4-23-30-17(15-34-11-9-33(3)10-12-34)13-21(32-23)20-6-5-18-19(31-20)7-8-22-24(18)25-26(36-22)27(35)29-16(2)14-28-25/h4-8,13,16,28H,1,9-12,14-15H2,2-3H3,(H,29,35) LLNHFYCXMOSNGM-UHFFFAOYSA-N 688868 US20240190890, Compound I-88::(R)-10-methyl-3-(6-((4-methylpiperazin-1-yl)methyl)-2-vinylpyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 15.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688868 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688868&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430070 504490538 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433685 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCN(C)CC3)nc(n2)C#C)C(=O)N1 InChI=1S/C27H27N7OS/c1-4-23-30-17(15-34-11-9-33(3)10-12-34)13-21(32-23)20-6-5-18-19(31-20)7-8-22-24(18)25-26(36-22)27(35)29-16(2)14-28-25/h1,5-8,13,16,28H,9-12,14-15H2,2-3H3,(H,29,35) OFDZFWQOGMCBJZ-UHFFFAOYSA-N 688869 US20240190890, Compound I-89::(R)-3-(2-ethynyl-6-((4-methylpiperazin-1-yl)methyl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 26.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688869 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688869&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430071 504490539 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433686 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cccc(n2)C(F)=C)C(=O)N1 InChI=1S/C22H17FN4OS/c1-11-10-24-20-19-13-6-7-17(16-5-3-4-14(26-16)12(2)23)27-15(13)8-9-18(19)29-21(20)22(28)25-11/h3-9,11,24H,2,10H2,1H3,(H,25,28) LPCPFSVKXROAOS-UHFFFAOYSA-N 688870 US20240190890, Compound I-90::(R)-3-(6-(1-fluorovinyl)pyridin-2-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 460 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688870 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688870&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542275 504490540 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433687 COc1nnc(cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C#C InChI=1S/C22H17N5O2S/c1-4-12-9-14(22(29-3)27-26-12)16-6-5-13-15(25-16)7-8-17-18(13)19-20(30-17)21(28)24-11(2)10-23-19/h1,5-9,11,23H,10H2,2-3H3,(H,24,28) QXXKEYUJNLDSTI-UHFFFAOYSA-N 688871 US20240190890, Compound I-91::(R)-3-(6-ethynyl-3-methoxypyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 26.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688871 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688871&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542206 504490541 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433688 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncc2C(F)F)C#C)C(=O)N1 InChI=1S/C23H16F2N4OS/c1-3-12-8-14(15(10-26-12)22(24)25)17-5-4-13-16(29-17)6-7-18-19(13)20-21(31-18)23(30)28-11(2)9-27-20/h1,4-8,10-11,22,27H,9H2,2H3,(H,28,30) FENAYSJQMSOLHM-UHFFFAOYSA-N 688872 US20240190890, Compound I-92::(R)-3-(5-(difluoromethyl)-2-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 17.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688872 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688872&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430072 504490542 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433689 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)ncc2C(F)F)C(=O)N1 InChI=1S/C21H15ClF2N4OS/c1-9-7-26-18-17-10-2-3-14(11-6-16(22)25-8-12(11)20(23)24)28-13(10)4-5-15(17)30-19(18)21(29)27-9/h2-6,8-9,20,26H,7H2,1H3,(H,27,29) KAIBYPNEQHWCHY-UHFFFAOYSA-N 688873 US20240190890, Compound I-93::(R)-3-(2-chloro-5-(difluoromethyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 238 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688873 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688873&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541875 504490543 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433690 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(c2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C25H25ClN6OS/c1-14-13-27-23-22-16-3-4-17(29-18(16)5-6-19(22)34-24(23)25(33)28-14)15-11-20(26)30-21(12-15)32-9-7-31(2)8-10-32/h3-6,11-12,14,27H,7-10,13H2,1-2H3,(H,28,33) IWNLTHZFPGOMBA-UHFFFAOYSA-N 688874 US20240190890, Compound I-94::(R)-3-(2-chloro-6-(4-methylpiperazin-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 43.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688874 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688874&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430073 504490544 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433691 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CCN(C)CC2)C#C)C(=O)N1 InChI=1S/C27H26N6OS/c1-4-18-13-17(14-23(30-18)33-11-9-32(3)10-12-33)20-6-5-19-21(31-20)7-8-22-24(19)25-26(35-22)27(34)29-16(2)15-28-25/h1,5-8,13-14,16,28H,9-12,15H2,2-3H3,(H,29,34) WNOGJJHITUPYLM-UHFFFAOYSA-N 688875 US20240190890, Compound I-172::(R)-3-(2-ethynyl-6-(4-methylpiperazin-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-95 MAP kinase-activated protein kinase 2 Homo sapiens 42.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688875 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688875&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430074 504490545 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433692 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C27H28N6OS/c1-4-18-13-17(14-23(30-18)33-11-9-32(3)10-12-33)20-6-5-19-21(31-20)7-8-22-24(19)25-26(35-22)27(34)29-16(2)15-28-25/h4-8,13-14,16,28H,1,9-12,15H2,2-3H3,(H,29,34) SKVCMCBKRCIKAY-UHFFFAOYSA-N 688876 US20240190890, Compound I-96::US20240190890, Compound I-171::(R)-10-methyl-3-(2-(4-methylpiperazin-1-yl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 10.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688876 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688876&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430075 504490546 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433693 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(CO)c2)C(=O)N1 InChI=1S/C21H17ClN4O2S/c1-10-8-23-19-18-13-2-3-14(11-6-12(9-27)25-17(22)7-11)26-15(13)4-5-16(18)29-20(19)21(28)24-10/h2-7,10,23,27H,8-9H2,1H3,(H,24,28) MJBZZBZLRALOFA-UHFFFAOYSA-N 688877 US20240190890, Compound I-97::(R)-3-(2-chloro-6-(hydroxymethyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 60.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688877 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688877&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542383 504490547 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433694 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CO)nc(c2)C#C)C(=O)N1 InChI=1S/C23H18N4O2S/c1-3-14-8-13(9-15(11-28)26-14)17-5-4-16-18(27-17)6-7-19-20(16)21-22(30-19)23(29)25-12(2)10-24-21/h1,4-9,12,24,28H,10-11H2,2H3,(H,25,29) UGGVWYDMJINZBG-UHFFFAOYSA-N 688878 US20240190890, Compound I-98::(R)-3-(2-ethynyl-6-(hydroxymethyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 60.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688878 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688878&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430076 504490548 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433695 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CO)nc(C=C)c2)C(=O)N1 InChI=1S/C23H20N4O2S/c1-3-14-8-13(9-15(11-28)26-14)17-5-4-16-18(27-17)6-7-19-20(16)21-22(30-19)23(29)25-12(2)10-24-21/h3-9,12,24,28H,1,10-11H2,2H3,(H,25,29) IURQLXGXCBYEKY-UHFFFAOYSA-N 688879 US20240190890, Compound I-99::(R)-3-(2-(hydroxymethyl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688879&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542207 504490549 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433696 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(c2)C2=CCN(C)CC2)C(=O)N1 |t:28| InChI=1S/C26H24ClN5OS/c1-14-13-28-24-23-17-3-4-18(30-19(17)5-6-21(23)34-25(24)26(33)29-14)16-11-20(31-22(27)12-16)15-7-9-32(2)10-8-15/h3-7,11-12,14,28H,8-10,13H2,1-2H3,(H,29,33) LUPYMWFXGJMBNW-UHFFFAOYSA-N 688880 US20240190890, Compound I-100::(R)-3-(6-chloro-1'-methyl-1',2',3',6'-tetrahydro-[2,4'-bipyridin]-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 62.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688880 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688880&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430077 504490550 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433697 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)C2=CCN(C)CC2)C(=O)N1 |t:29| InChI=1S/C28H27N5OS/c1-4-19-13-18(14-23(31-19)17-9-11-33(3)12-10-17)21-6-5-20-22(32-21)7-8-24-25(20)26-27(35-24)28(34)30-16(2)15-29-26/h4-9,13-14,16,29H,1,10-12,15H2,2-3H3,(H,30,34) BVYBHWZLOVCVIV-UHFFFAOYSA-N 688881 US20240190890, Compound I-101::(R)-10-methyl-3-(1'-methyl-6-vinyl-1',2',3',6'-tetrahydro-[2,4'-bipyridin]-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 8.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688881 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688881&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430078 504490551 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433698 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)C2=CCN(C)CC2)C#C)C(=O)N1 |t:27| InChI=1S/C28H25N5OS/c1-4-19-13-18(14-23(31-19)17-9-11-33(3)12-10-17)21-6-5-20-22(32-21)7-8-24-25(20)26-27(35-24)28(34)30-16(2)15-29-26/h1,5-9,13-14,16,29H,10-12,15H2,2-3H3,(H,30,34) OUXBVSIMBIWEJQ-UHFFFAOYSA-N 688882 US20240190890, Compound I-102::(R)-3-(6-ethynyl-1'-methyl-1',2',3',6'-tetrahydro-[2,4'-bipyridin]-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 8.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688882 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688882&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430079 504490552 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433699 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nc(c2)C2CCN(C)CC2)C(=O)N1 InChI=1S/C26H26ClN5OS/c1-14-13-28-24-23-17-3-4-18(30-19(17)5-6-21(23)34-25(24)26(33)29-14)16-11-20(31-22(27)12-16)15-7-9-32(2)10-8-15/h3-6,11-12,14-15,28H,7-10,13H2,1-2H3,(H,29,33) BGYNTCGGWNGKAN-UHFFFAOYSA-N 688883 US20240190890, Compound I-103::(R)-3-(2-chloro-6-(1-methylpiperidin-4-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 46.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688883 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688883&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430080 504490553 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433700 CNc1nnc(cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C#C InChI=1S/C22H18N6OS/c1-4-12-9-14(21(23-3)28-27-12)16-6-5-13-15(26-16)7-8-17-18(13)19-20(30-17)22(29)25-11(2)10-24-19/h1,5-9,11,24H,10H2,2-3H3,(H,23,28)(H,25,29) UDPCYPFQMQTGMT-UHFFFAOYSA-N 688884 US20240190890, Compound I-104::(R)-3-(6-ethynyl-3-(methylamino)pyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 194 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688884 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688884&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430081 504490554 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433701 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nnc2N(C)C)C#C)C(=O)N1 InChI=1S/C23H20N6OS/c1-5-13-10-15(22(28-27-13)29(3)4)17-7-6-14-16(26-17)8-9-18-19(14)20-21(31-18)23(30)25-12(2)11-24-20/h1,6-10,12,24H,11H2,2-4H3,(H,25,30) KQZVSHNLQHIBEV-UHFFFAOYSA-N 688885 US20240190890, Compound I-105::(R)-3-(3-(dimethylamino)-6-ethynylpyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 118 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688885 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688885&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430082 504490555 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433702 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)C2CCN(C)CC2)C(=O)N1 InChI=1S/C28H29N5OS/c1-4-19-13-18(14-23(31-19)17-9-11-33(3)12-10-17)21-6-5-20-22(32-21)7-8-24-25(20)26-27(35-24)28(34)30-16(2)15-29-26/h4-8,13-14,16-17,29H,1,9-12,15H2,2-3H3,(H,30,34) VORXTDOHSCBTLQ-UHFFFAOYSA-N 688886 US20240190890, Compound I-106::(R)-10-methyl-3-(2-(1-methylpiperidin-4-yl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 8.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688886 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688886&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430083 504490556 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433703 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)C2CCN(C)CC2)C#C)C(=O)N1 InChI=1S/C28H27N5OS/c1-4-19-13-18(14-23(31-19)17-9-11-33(3)12-10-17)21-6-5-20-22(32-21)7-8-24-25(20)26-27(35-24)28(34)30-16(2)15-29-26/h1,5-8,13-14,16-17,29H,9-12,15H2,2-3H3,(H,30,34) KPCQIPFDACJZEV-UHFFFAOYSA-N 688887 US20240190890, Compound I-107::(R)-3-(2-ethynyl-6-(1-methylpiperidin-4-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 22.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688887 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688887&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430084 504490557 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433704 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(c2)C(F)=C)C(=O)N1 InChI=1S/C22H17FN4OS/c1-11-10-25-20-19-14-3-4-15(13-7-8-24-17(9-13)12(2)23)27-16(14)5-6-18(19)29-21(20)22(28)26-11/h3-9,11,25H,2,10H2,1H3,(H,26,28) WTGTUQRPDSIEJV-UHFFFAOYSA-N 688888 US20240190890, Compound I-108::(R)-3-(2-(1-fluorovinyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 122 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688888 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688888&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542284 504490558 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433705 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2C)C(=O)N1 InChI=1S/C23H20N4OS/c1-4-14-9-16(12(2)10-24-14)18-6-5-15-17(27-18)7-8-19-20(15)21-22(29-19)23(28)26-13(3)11-25-21/h4-10,13,25H,1,11H2,2-3H3,(H,26,28) UIPAEGAJTRBGJU-UHFFFAOYSA-N 688889 US20240190890, Compound I-142::(R)-10-methyl-3-(5-methyl-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-109::US20240190890, Compound I-249 MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688889 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688889&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541925 504490559 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433706 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C)nc(C=C)c2)C(=O)N1 InChI=1S/C23H20N4OS/c1-4-15-10-14(9-12(2)25-15)17-6-5-16-18(27-17)7-8-19-20(16)21-22(29-19)23(28)26-13(3)11-24-21/h4-10,13,24H,1,11H2,2-3H3,(H,26,28) SBMAULXQGBRRSW-UHFFFAOYSA-N 688890 US20240190890, Compound I-110::(R)-10-methyl-3-(2-methyl-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 8.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688890 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688890&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541949 504490560 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433707 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncc2C)C#C)C(=O)N1 InChI=1S/C23H18N4OS/c1-4-14-9-16(12(2)10-24-14)18-6-5-15-17(27-18)7-8-19-20(15)21-22(29-19)23(28)26-13(3)11-25-21/h1,5-10,13,25H,11H2,2-3H3,(H,26,28) YAJDXWWVQTVUAE-UHFFFAOYSA-N 688891 US20240190890, Compound I-111::(R)-3-(2-ethynyl-5-methylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 104 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688891 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688891&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542293 504490561 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433708 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C)nc(c2)C#C)C(=O)N1 InChI=1S/C23H18N4OS/c1-4-15-10-14(9-12(2)25-15)17-6-5-16-18(27-17)7-8-19-20(16)21-22(29-19)23(28)26-13(3)11-24-21/h1,5-10,13,24H,11H2,2-3H3,(H,26,28) VLFAMVMCKKWWOK-UHFFFAOYSA-N 688892 US20240190890, Compound I-112::(R)-3-(2-ethynyl-6-methylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 152 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688892 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688892&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542305 504490562 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433709 C\C=C\c1cc(ccn1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C23H20N4OS/c1-3-4-15-11-14(9-10-24-15)17-6-5-16-18(27-17)7-8-19-20(16)21-22(29-19)23(28)26-13(2)12-25-21/h3-11,13,25H,12H2,1-2H3,(H,26,28) HQYVARCYMGZQEP-UHFFFAOYSA-N 688893 US20240190890, Compound I-113::(R,E)-10-methyl-3-(2-(prop-1-en-1-yl)pyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 53.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688893 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688893&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542322 504490563 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433710 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(\C=C\CN(C)C)c2)C(=O)N1 InChI=1S/C25H25N5OS/c1-15-14-27-23-22-18-6-7-19(16-10-11-26-17(13-16)5-4-12-30(2)3)29-20(18)8-9-21(22)32-24(23)25(31)28-15/h4-11,13,15,27H,12,14H2,1-3H3,(H,28,31) IYECGBXOLJNWAH-UHFFFAOYSA-N 688894 US20240190890, Compound I-114::(R,E)-3-(2-(3-(dimethylamino)prop-1-en-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 11.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688894 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688894&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430085 504490564 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433711 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(\C=C\CN(C)C)ncn2)C(=O)N1 InChI=1S/C24H24N6OS/c1-14-12-25-22-21-16-6-7-18(19-11-15(26-13-27-19)5-4-10-30(2)3)29-17(16)8-9-20(21)32-23(22)24(31)28-14/h4-9,11,13-14,25H,10,12H2,1-3H3,(H,28,31) GXJXOYJQXJANPO-UHFFFAOYSA-N 688895 US20240190890, Compound I-115::(R,E)-3-(6-(3-(dimethylamino)prop-1-en-1-yl)pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 37.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688895 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688895&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430086 504490565 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433712 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(c2)C(=C)CN2CCCC2)C(=O)N1 InChI=1S/C27H27N5OS/c1-16(15-32-11-3-4-12-32)22-13-18(9-10-28-22)20-6-5-19-21(31-20)7-8-23-24(19)25-26(34-23)27(33)30-17(2)14-29-25/h5-10,13,17,29H,1,3-4,11-12,14-15H2,2H3,(H,30,33) RWRSVHUIDMAEHB-UHFFFAOYSA-N 688896 US20240190890, Compound I-116::(R)-10-methyl-3-(2-(3-(pyrrolidin-1-yl)prop-1-en-2-yl)pyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 6.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688896 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688896&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430087 504490566 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433713 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(c2)C(=C)CN(C)C)C(=O)N1 InChI=1S/C25H25N5OS/c1-14(13-30(3)4)20-11-16(9-10-26-20)18-6-5-17-19(29-18)7-8-21-22(17)23-24(32-21)25(31)28-15(2)12-27-23/h5-11,15,27H,1,12-13H2,2-4H3,(H,28,31) FSEUONAMDJCUDY-UHFFFAOYSA-N 688897 US20240190890, Compound I-117::(R)-3-(2-(3-(dimethylamino)prop-1-en-2-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 6.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688897 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688897&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430088 504490567 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433714 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nnc2OCCN2CCCC2)C(=O)N1 InChI=1S/C27H28N6O2S/c1-3-17-14-19(27(32-31-17)35-13-12-33-10-4-5-11-33)21-7-6-18-20(30-21)8-9-22-23(18)24-25(36-22)26(34)29-16(2)15-28-24/h3,6-9,14,16,28H,1,4-5,10-13,15H2,2H3,(H,29,34) KQYQIJVQCDCOJY-UHFFFAOYSA-N 688898 US20240190890, Compound I-118::(R)-10-methyl-3-(3-(2-(pyrrolidin-1-yl)ethoxy)-6-vinylpyridazin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 28.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688898 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688898&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541964 504490568 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433715 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nnc2OCCN2CCCC2)C(=O)N1 InChI=1S/C25H25ClN6O2S/c1-14-13-27-22-21-15-4-5-18(29-17(15)6-7-19(21)35-23(22)24(33)28-14)16-12-20(26)30-31-25(16)34-11-10-32-8-2-3-9-32/h4-7,12,14,27H,2-3,8-11,13H2,1H3,(H,28,33) OPUHQGPVIVKKTM-UHFFFAOYSA-N 688899 US20240190890, Compound I-119::(R)-3-(6-chloro-3-(2-(pyrrolidin-1-yl)ethoxy)pyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 981 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688899 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688899&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542148 504490569 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433716 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nnc2OCCN2CCCC2)C#C)C(=O)N1 InChI=1S/C27H26N6O2S/c1-3-17-14-19(27(32-31-17)35-13-12-33-10-4-5-11-33)21-7-6-18-20(30-21)8-9-22-23(18)24-25(36-22)26(34)29-16(2)15-28-24/h1,6-9,14,16,28H,4-5,10-13,15H2,2H3,(H,29,34) VEDDMAQWBXLXLT-UHFFFAOYSA-N 688900 US20240190890, Compound I-120::(R)-3-(6-ethynyl-3-(2-(pyrrolidin-1-yl)ethoxy)pyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 45.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688900 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688900&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542124 504490570 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433717 COC1CCN(Cc2cc(cc(C=C)n2)-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)CC1 InChI=1S/C29H31N5O2S/c1-4-19-13-18(14-20(32-19)16-34-11-9-21(36-3)10-12-34)23-6-5-22-24(33-23)7-8-25-26(22)27-28(37-25)29(35)31-17(2)15-30-27/h4-8,13-14,17,21,30H,1,9-12,15-16H2,2-3H3,(H,31,35) LTPUVIRHJZGDHQ-UHFFFAOYSA-N 688901 US20240190890, Compound I-121::(R)-3-(2-((4-methoxypiperidin-1-yl)methyl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 11.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688901 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688901&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430089 504490571 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433718 COC1CCN(Cc2cc(cc(n2)C#C)-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)CC1 InChI=1S/C29H29N5O2S/c1-4-19-13-18(14-20(32-19)16-34-11-9-21(36-3)10-12-34)23-6-5-22-24(33-23)7-8-25-26(22)27-28(37-25)29(35)31-17(2)15-30-27/h1,5-8,13-14,17,21,30H,9-12,15-16H2,2-3H3,(H,31,35) YZJKUXOKVBMAQN-UHFFFAOYSA-N 688902 US20240190890, Compound I-122::(R)-3-(2-ethynyl-6-((4-methoxypiperidin-1-yl)methyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 40.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688902 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688902&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430090 504490572 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433719 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCC(F)(F)CC3)nc(C=C)c2)C(=O)N1 InChI=1S/C28H27F2N5OS/c1-3-18-12-17(13-19(33-18)15-35-10-8-28(29,30)9-11-35)21-5-4-20-22(34-21)6-7-23-24(20)25-26(37-23)27(36)32-16(2)14-31-25/h3-7,12-13,16,31H,1,8-11,14-15H2,2H3,(H,32,36) ADLZSLXFBIMKSF-UHFFFAOYSA-N 688903 US20240190890, Compound I-123::(R)-3-(2-((4,4-difluoropiperidin-1-yl)methyl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 31.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688903 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688903&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430091 504490573 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433720 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCC(F)(F)CC3)nc(c2)C#C)C(=O)N1 InChI=1S/C28H25F2N5OS/c1-3-18-12-17(13-19(33-18)15-35-10-8-28(29,30)9-11-35)21-5-4-20-22(34-21)6-7-23-24(20)25-26(37-23)27(36)32-16(2)14-31-25/h1,4-7,12-13,16,31H,8-11,14-15H2,2H3,(H,32,36) LMQLFLWGIYEHSF-UHFFFAOYSA-N 688904 US20240190890, Compound I-124::(R)-3-(2-((4,4-difluoropiperidin-1-yl)methyl)-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 125 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688904 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688904&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430092 504490574 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433721 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCN(C)CC3)nc(C=C)c2)C(=O)N1 InChI=1S/C28H30N6OS/c1-4-19-13-18(14-20(31-19)16-34-11-9-33(3)10-12-34)22-6-5-21-23(32-22)7-8-24-25(21)26-27(36-24)28(35)30-17(2)15-29-26/h4-8,13-14,17,29H,1,9-12,15-16H2,2-3H3,(H,30,35) SWFPIQSGYWDQEG-UHFFFAOYSA-N 688905 US20240190890, Compound I-125::(R)-10-methyl-3-(2-((4-methylpiperazin-1-yl)methyl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688905 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688905&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430093 504490575 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433722 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCN(C)CC3)nc(c2)C#C)C(=O)N1 InChI=1S/C28H28N6OS/c1-4-19-13-18(14-20(31-19)16-34-11-9-33(3)10-12-34)22-6-5-21-23(32-22)7-8-24-25(21)26-27(36-24)28(35)30-17(2)15-29-26/h1,5-8,13-14,17,29H,9-12,15-16H2,2-3H3,(H,30,35) KRWYXHVGWOAVMD-UHFFFAOYSA-N 688906 US20240190890, Compound I-126::(R)-3-(2-ethynyl-6-((4-methylpiperazin-1-yl)methyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 34.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688906 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688906&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430094 504490576 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433723 COc1nnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H19N5O2S/c1-4-12-9-14(22(29-3)27-26-12)16-6-5-13-15(25-16)7-8-17-18(13)19-20(30-17)21(28)24-11(2)10-23-19/h4-9,11,23H,1,10H2,2-3H3,(H,24,28) DHCHMLYGPFHTQJ-UHFFFAOYSA-N 688907 US20240190890, Compound I-127::(R)-3-(3-methoxy-6-vinylpyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 50.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688907 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688907&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542029 504490577 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433724 CNc1nnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C22H20N6OS/c1-4-12-9-14(21(23-3)28-27-12)16-6-5-13-15(26-16)7-8-17-18(13)19-20(30-17)22(29)25-11(2)10-24-19/h4-9,11,24H,1,10H2,2-3H3,(H,23,28)(H,25,29) AGFVUKSTSQBNOK-UHFFFAOYSA-N 688908 US20240190890, Compound I-128::(R)-10-methyl-3-(3-(methylamino)-6-vinylpyridazin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 19.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688908 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688908&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542277 504490578 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433725 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nnc2N(C)C)C(=O)N1 InChI=1S/C23H22N6OS/c1-5-13-10-15(22(28-27-13)29(3)4)17-7-6-14-16(26-17)8-9-18-19(14)20-21(31-18)23(30)25-12(2)11-24-20/h5-10,12,24H,1,11H2,2-4H3,(H,25,30) XGAWZPVBAFCZDI-UHFFFAOYSA-N 688909 US20240190890, Compound I-129::(R)-3-(3-(dimethylamino)-6-vinylpyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 106 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688909 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688909&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542137 504490579 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433726 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2C(F)F)C(=O)N1 InChI=1S/C23H18F2N4OS/c1-3-12-8-14(15(10-26-12)22(24)25)17-5-4-13-16(29-17)6-7-18-19(13)20-21(31-18)23(30)28-11(2)9-27-20/h3-8,10-11,22,27H,1,9H2,2H3,(H,28,30) JRWMTUSHUREILA-UHFFFAOYSA-N 688910 US20240190890, Compound I-130::(R)-3-(5-(difluoromethyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688910 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688910&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542373 504490580 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433727 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(c2)C(=C)CN2CCOCC2)C(=O)N1 InChI=1S/C27H27N5O2S/c1-16(15-32-9-11-34-12-10-32)22-13-18(7-8-28-22)20-4-3-19-21(31-20)5-6-23-24(19)25-26(35-23)27(33)30-17(2)14-29-25/h3-8,13,17,29H,1,9-12,14-15H2,2H3,(H,30,33) JWOWVWPODVNPLN-UHFFFAOYSA-N 688911 US20240190890, Compound I-131::(R)-10-methyl-3-(2-(3-morpholinoprop-1-en-2-yl)pyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 3.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688911 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688911&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430095 504490581 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433728 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)nnc2OCCN2CCOCC2)C(=O)N1 InChI=1S/C25H25ClN6O3S/c1-14-13-27-22-21-15-2-3-18(29-17(15)4-5-19(21)36-23(22)24(33)28-14)16-12-20(26)30-31-25(16)35-11-8-32-6-9-34-10-7-32/h2-5,12,14,27H,6-11,13H2,1H3,(H,28,33) MMWJNEQHYXXMQT-UHFFFAOYSA-N 688912 US20240190890, Compound I-132::(R)-3-(6-chloro-3-(2-morpholinoethoxy)pyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 912 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688912 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688912&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542061 504490582 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433729 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nnc2OCCN2CCOCC2)C(=O)N1 InChI=1S/C27H28N6O3S/c1-3-17-14-19(27(32-31-17)36-13-10-33-8-11-35-12-9-33)21-5-4-18-20(30-21)6-7-22-23(18)24-25(37-22)26(34)29-16(2)15-28-24/h3-7,14,16,28H,1,8-13,15H2,2H3,(H,29,34) NVXRKYFORQERFU-UHFFFAOYSA-N 688913 US20240190890, Compound I-133::(R)-10-methyl-3-(3-(2-morpholinoethoxy)-6-vinylpyridazin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 255 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688913 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688913&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542379 504490583 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433730 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nnc2OCCN2CCOCC2)C#C)C(=O)N1 InChI=1S/C27H26N6O3S/c1-3-17-14-19(27(32-31-17)36-13-10-33-8-11-35-12-9-33)21-5-4-18-20(30-21)6-7-22-23(18)24-25(37-22)26(34)29-16(2)15-28-24/h1,4-7,14,16,28H,8-13,15H2,2H3,(H,29,34) FRUNFRCJEUVKFO-UHFFFAOYSA-N 688914 US20240190890, Compound I-134::(R)-3-(6-ethynyl-3-(2-morpholinoethoxy)pyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 137 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688914 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688914&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541884 504490584 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433731 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(c2)C#CC(C)(C)N)C(=O)N1 InChI=1S/C25H23N5OS/c1-14-13-28-22-21-17-4-5-18(15-9-11-27-16(12-15)8-10-25(2,3)26)30-19(17)6-7-20(21)32-23(22)24(31)29-14/h4-7,9,11-12,14,28H,13,26H2,1-3H3,(H,29,31) HKRFWZRSIUXYOG-UHFFFAOYSA-N 688915 US20240190890, Compound I-135::(R)-3-(2-(3-amino-3-methylbut-1-yn-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 15.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688915 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688915&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430096 504490585 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433732 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nnc2C)C(=O)N1 InChI=1S/C22H19N5OS/c1-4-13-9-15(12(3)26-27-13)17-6-5-14-16(25-17)7-8-18-19(14)20-21(29-18)22(28)24-11(2)10-23-20/h4-9,11,23H,1,10H2,2-3H3,(H,24,28) PUCLLMWLMLGNTN-UHFFFAOYSA-N 688916 US20240190890, Compound I-136::(R)-10-methyl-3-(3-methyl-6-vinylpyridazin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 9.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688916 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688916&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542260 504490586 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433733 COC(=O)c1nnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C23H19N5O3S/c1-4-12-9-14(19(28-27-12)23(30)31-3)16-6-5-13-15(26-16)7-8-17-18(13)20-21(32-17)22(29)25-11(2)10-24-20/h4-9,11,24H,1,10H2,2-3H3,(H,25,29) YPFNZJJHCGKEGV-UHFFFAOYSA-N 688917 US20240190890, Compound I-137::methyl (R)-4-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)-6-vinylpyridazine-3-carboxylate MAP kinase-activated protein kinase 2 Homo sapiens 3.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688917 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688917&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542285 504490587 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433734 COc1nnc(cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1)C(=C)CN1CCOCC1 InChI=1S/C27H28N6O3S/c1-15(14-33-8-10-36-11-9-33)21-12-18(27(35-3)32-31-21)20-5-4-17-19(30-20)6-7-22-23(17)24-25(37-22)26(34)29-16(2)13-28-24/h4-7,12,16,28H,1,8-11,13-14H2,2-3H3,(H,29,34) KCTMDNGIKPHXPN-UHFFFAOYSA-N 688918 US20240190890, Compound I-138::(R)-3-(3-methoxy-6-(3-morpholinoprop-1-en-2-yl)pyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 96.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688918 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688918&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430097 504490588 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433735 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncn2)C(=C)CN2CCOCC2)C(=O)N1 InChI=1S/C26H26N6O2S/c1-15(13-32-7-9-34-10-8-32)20-11-21(29-14-28-20)19-4-3-17-18(31-19)5-6-22-23(17)24-25(35-22)26(33)30-16(2)12-27-24/h3-6,11,14,16,27H,1,7-10,12-13H2,2H3,(H,30,33) MGRAOTDXRNYSHM-UHFFFAOYSA-N 688919 US20240190890, Compound I-139::(R)-10-methyl-3-(6-(3-morpholinoprop-1-en-2-yl)pyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688919 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688919&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430098 504490589 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433736 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCOCC3)nc(C=C)c2)C(=O)N1 InChI=1S/C27H27N5O2S/c1-3-18-12-17(13-19(30-18)15-32-8-10-34-11-9-32)21-5-4-20-22(31-21)6-7-23-24(20)25-26(35-23)27(33)29-16(2)14-28-25/h3-7,12-13,16,28H,1,8-11,14-15H2,2H3,(H,29,33) BMQYAZWDICUYDI-UHFFFAOYSA-N 688920 US20240190890, Compound I-140::(R)-10-methyl-3-(2-(morpholinomethyl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 14.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688920 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688920&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542169 504490590 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433737 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCC4(CC4(F)F)CC3)nc(C=C)c2)C(=O)N1 InChI=1S/C30H29F2N5OS/c1-3-19-12-18(13-20(35-19)15-37-10-8-29(9-11-37)16-30(29,31)32)22-5-4-21-23(36-22)6-7-24-25(21)26-27(39-24)28(38)34-17(2)14-33-26/h3-7,12-13,17,33H,1,8-11,14-16H2,2H3,(H,34,38) KOULXTCAIAQQSF-UHFFFAOYSA-N 688921 US20240190890, Compound I-141::(R)-3-(2-((1,1-difluoro-6-azaspiro[2.5]octan-6-yl)methyl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 111 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688921 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688921&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430099 504490591 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433738 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2C)C(=O)N1 InChI=1S/C23H20N4OS/c1-4-14-9-16(12(2)10-24-14)18-6-5-15-17(27-18)7-8-19-20(15)21-22(29-19)23(28)26-13(3)11-25-21/h4-10,13,25H,1,11H2,2-3H3,(H,26,28) UIPAEGAJTRBGJU-UHFFFAOYSA-N 688889 US20240190890, Compound I-142::(R)-10-methyl-3-(5-methyl-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-109::US20240190890, Compound I-249 MAP kinase-activated protein kinase 2 Homo sapiens 9.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688889 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688889&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541925 504490559 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433739 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2Cl)C(=O)N1 InChI=1S/C22H17ClN4OS/c1-3-12-8-14(15(23)10-24-12)17-5-4-13-16(27-17)6-7-18-19(13)20-21(29-18)22(28)26-11(2)9-25-20/h3-8,10-11,25H,1,9H2,2H3,(H,26,28) UCDYBUDRRVOLLY-UHFFFAOYSA-N 688923 US20240190890, Compound I-143::(R)-3-(5-chloro-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 59.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688923 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688923&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542393 504490592 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433740 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncc2Cl)C#C)C(=O)N1 InChI=1S/C22H15ClN4OS/c1-3-12-8-14(15(23)10-24-12)17-5-4-13-16(27-17)6-7-18-19(13)20-21(29-18)22(28)26-11(2)9-25-20/h1,4-8,10-11,25H,9H2,2H3,(H,26,28) FNDVFSVVKMGIMM-UHFFFAOYSA-N 688924 US20240190890, Compound I-144::(R)-3-(5-chloro-2-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 678 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688924 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688924&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542290 504490593 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433741 COc1nnc(\C=C\CN(C)C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C25H26N6O2S/c1-14-13-26-22-21-16-7-8-19(28-18(16)9-10-20(21)34-23(22)24(32)27-14)17-12-15(6-5-11-31(2)3)29-30-25(17)33-4/h5-10,12,14,26H,11,13H2,1-4H3,(H,27,32) QHMFUQLWIACBQV-UHFFFAOYSA-N 688925 US20240190890, Compound I-145::(R,E)-3-(6-(3-(dimethylamino)prop-1-en-1-yl)-3-methoxypyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 273 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688925 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688925&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430100 504490594 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433742 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2c(C=C)cnn2C)C(=O)N1 InChI=1S/C21H19N5OS/c1-4-12-10-23-26(3)19(12)15-6-5-13-14(25-15)7-8-16-17(13)18-20(28-16)21(27)24-11(2)9-22-18/h4-8,10-11,22H,1,9H2,2-3H3,(H,24,27) ZHWJMPTWQQQPGB-UHFFFAOYSA-N 688926 US20240190890, Compound I-146::(R)-10-methyl-3-(1-methyl-4-vinyl-1H-pyrazol-5-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 499 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688926 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688926&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542110 504490595 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433743 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2ccc(C=C)n2)C(=O)N1 InChI=1S/C20H17N5OS/c1-3-12-8-9-25(24-12)16-7-4-13-14(23-16)5-6-15-17(13)18-19(27-15)20(26)22-11(2)10-21-18/h3-9,11,21H,1,10H2,2H3,(H,22,26) HSEROCVHILWAMK-UHFFFAOYSA-N 688927 US20240190890, Compound I-147::(R)-10-methyl-3-(3-vinyl-1H-pyrazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 104 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688927 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688927&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542050 504490596 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433744 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2cc(C=C)cn2)C(=O)N1 InChI=1S/C20H17N5OS/c1-3-12-9-22-25(10-12)16-7-4-13-14(24-16)5-6-15-17(13)18-19(27-15)20(26)23-11(2)8-21-18/h3-7,9-11,21H,1,8H2,2H3,(H,23,26) RXSUNGJNNIOTNW-UHFFFAOYSA-N 688928 US20240190890, Compound I-148::(R)-10-methyl-3-(4-vinyl-1H-pyrazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 101 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688928 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688928&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542263 504490597 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433745 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)cs2)C(=O)N1 InChI=1S/C20H16N4OS2/c1-3-11-9-26-20(23-11)14-5-4-12-13(24-14)6-7-15-16(12)17-18(27-15)19(25)22-10(2)8-21-17/h3-7,9-10,21H,1,8H2,2H3,(H,22,25) FGXPIMCFDDFFEJ-UHFFFAOYSA-N 688929 US20240190890, Compound I-149::(R)-10-methyl-3-(4-vinylthiazol-2-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 95.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688929 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688929&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541982 504490598 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433746 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cnc(C=C)[nH]2)C(=O)N1 InChI=1S/C20H17N5OS/c1-3-16-21-9-14(25-16)13-5-4-11-12(24-13)6-7-15-17(11)18-19(27-15)20(26)23-10(2)8-22-18/h3-7,9-10,22H,1,8H2,2H3,(H,21,25)(H,23,26) HQJUHDNSROEHOB-UHFFFAOYSA-N 688930 US20240190890, Compound I-150::(R)-10-methyl-3-(2-vinyl-1H-imidazol-5-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 14.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688930 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688930&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542120 504490599 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433747 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cnc(Cl)[nH]2)C(=O)N1 InChI=1S/C18H14ClN5OS/c1-8-6-20-15-14-9-2-3-11(12-7-21-18(19)24-12)23-10(9)4-5-13(14)26-16(15)17(25)22-8/h2-5,7-8,20H,6H2,1H3,(H,21,24)(H,22,25) BEHCJVVOIYYKQB-UHFFFAOYSA-N 688931 US20240190890, Compound I-151::(R)-3-(2-chloro-1H-imidazol-5-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 23.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688931 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688931&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542391 504490600 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433748 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2cc(Cl)cn2)C(=O)N1 InChI=1S/C18H14ClN5OS/c1-9-6-20-16-15-11-2-5-14(24-8-10(19)7-21-24)23-12(11)3-4-13(15)26-17(16)18(25)22-9/h2-5,7-9,20H,6H2,1H3,(H,22,25) ZRCZMVSRZWDVQG-UHFFFAOYSA-N 688932 US20240190890, Compound I-152::(R)-3-(4-chloro-1H-pyrazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 86.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688932 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688932&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541952 504490601 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433749 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2CN2CCOCC2)C(=O)N1 InChI=1S/C27H27N5O2S/c1-3-18-12-20(17(14-28-18)15-32-8-10-34-11-9-32)22-5-4-19-21(31-22)6-7-23-24(19)25-26(35-23)27(33)30-16(2)13-29-25/h3-7,12,14,16,29H,1,8-11,13,15H2,2H3,(H,30,33) KXDITUZTZBMLCJ-UHFFFAOYSA-N 688933 US20240190890, Compound I-153::(R)-10-methyl-3-(5-(morpholinomethyl)-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 23.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688933 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688933&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541977 504490602 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433750 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncc2CN2CCOCC2)C#C)C(=O)N1 InChI=1S/C27H25N5O2S/c1-3-18-12-20(17(14-28-18)15-32-8-10-34-11-9-32)22-5-4-19-21(31-22)6-7-23-24(19)25-26(35-23)27(33)30-16(2)13-29-25/h1,4-7,12,14,16,29H,8-11,13,15H2,2H3,(H,30,33) JCKCJHZWXLBHKG-UHFFFAOYSA-N 688934 US20240190890, Compound I-154::(R)-3-(2-ethynyl-5-(morpholinomethyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 49.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688934 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688934&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542197 504490603 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433751 COC1CCN(Cc2cnc(C=C)cc2-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)CC1 InChI=1S/C29H31N5O2S/c1-4-19-13-22(18(15-30-19)16-34-11-9-20(36-3)10-12-34)24-6-5-21-23(33-24)7-8-25-26(21)27-28(37-25)29(35)32-17(2)14-31-27/h4-8,13,15,17,20,31H,1,9-12,14,16H2,2-3H3,(H,32,35) NAELSHMKTISENA-UHFFFAOYSA-N 688935 US20240190890, Compound I-155::(R)-3-(5-((4-methoxypiperidin-1-yl)methyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 95.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688935 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688935&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541908 504490604 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433752 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCOCC2)C(=O)N1 InChI=1S/C26H25N5O2S/c1-3-17-12-16(13-22(29-17)31-8-10-33-11-9-31)19-5-4-18-20(30-19)6-7-21-23(18)24-25(34-21)26(32)28-15(2)14-27-24/h3-7,12-13,15,27H,1,8-11,14H2,2H3,(H,28,32) DSKNNOOEURGECC-UHFFFAOYSA-N 688936 US20240190890, Compound I-156::(R)-10-methyl-3-(2-morpholino-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 23.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688936 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688936&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542271 504490605 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433753 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CCOCC2)C#C)C(=O)N1 InChI=1S/C26H23N5O2S/c1-3-17-12-16(13-22(29-17)31-8-10-33-11-9-31)19-5-4-18-20(30-19)6-7-21-23(18)24-25(34-21)26(32)28-15(2)14-27-24/h1,4-7,12-13,15,27H,8-11,14H2,2H3,(H,28,32) SOLIEJNDAWYGRK-UHFFFAOYSA-N 688937 US20240190890, Compound I-157::(R)-3-(2-ethynyl-6-morpholinopyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 214 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688937 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688937&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542300 504490606 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433754 COC1CCN(CC1)c1cc(cc(C=C)n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C28H29N5O2S/c1-4-18-13-17(14-24(31-18)33-11-9-19(35-3)10-12-33)21-6-5-20-22(32-21)7-8-23-25(20)26-27(36-23)28(34)30-16(2)15-29-26/h4-8,13-14,16,19,29H,1,9-12,15H2,2-3H3,(H,30,34) GGADGERMSFVZDV-UHFFFAOYSA-N 688938 US20240190890, Compound I-158::(R)-3-(2-(4-methoxypiperidin-1-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 38.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688938 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688938&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430101 504490607 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433755 COC1CCN(CC1)c1cc(cc(n1)C#C)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C28H27N5O2S/c1-4-18-13-17(14-24(31-18)33-11-9-19(35-3)10-12-33)21-6-5-20-22(32-21)7-8-23-25(20)26-27(36-23)28(34)30-16(2)15-29-26/h1,5-8,13-14,16,19,29H,9-12,15H2,2-3H3,(H,30,34) PNLAJHBCGORDBA-UHFFFAOYSA-N 688939 US20240190890, Compound I-159::(R)-3-(2-ethynyl-6-(4-methoxypiperidin-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 189 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688939 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688939&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542348 504490608 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433756 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(Cl)ncc2C#N)C(=O)N1 InChI=1S/C21H14ClN5OS/c1-10-8-25-19-18-12-2-3-15(13-6-17(22)24-9-11(13)7-23)27-14(12)4-5-16(18)29-20(19)21(28)26-10/h2-6,9-10,25H,8H2,1H3,(H,26,28) BKCGRXWDZNSECE-UHFFFAOYSA-N 688940 US20240190890, Compound I-160::(R)-6-chloro-4-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)nicotinonitrile MAP kinase-activated protein kinase 2 Homo sapiens 3.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688940 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688940&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542340 504490609 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433757 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2C#N)C(=O)N1 InChI=1S/C23H17N5OS/c1-3-14-8-16(13(9-24)11-25-14)18-5-4-15-17(28-18)6-7-19-20(15)21-22(30-19)23(29)27-12(2)10-26-21/h3-8,11-12,26H,1,10H2,2H3,(H,27,29) BFFQFIKOBBAGPW-UHFFFAOYSA-N 688941 US20240190890, Compound I-161::(R)-4-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)-6-vinylnicotinonitrile MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688941 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688941&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430102 504490610 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433758 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(ncc2C#N)C#C)C(=O)N1 InChI=1S/C23H15N5OS/c1-3-14-8-16(13(9-24)11-25-14)18-5-4-15-17(28-18)6-7-19-20(15)21-22(30-19)23(29)27-12(2)10-26-21/h1,4-8,11-12,26H,10H2,2H3,(H,27,29) DMNATCTWKGWGCB-UHFFFAOYSA-N 688942 US20240190890, Compound I-162::(R)-6-ethynyl-4-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)nicotinonitrile MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688942 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688942&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542331 504490611 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433759 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cncc(C=C)n2)C(=O)N1 InChI=1S/C21H17N5OS/c1-3-12-9-22-10-16(25-12)15-5-4-13-14(26-15)6-7-17-18(13)19-20(28-17)21(27)24-11(2)8-23-19/h3-7,9-11,23H,1,8H2,2H3,(H,24,27) YBTDVWPEJPMSRK-UHFFFAOYSA-N 688943 US20240190890, Compound I-163::(R)-10-methyl-3-(6-vinylpyrazin-2-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 109 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688943 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688943&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542354 504490612 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433760 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2ccnc2C=C)C(=O)N1 InChI=1S/C20H17N5OS/c1-3-15-21-8-9-25(15)16-7-4-12-13(24-16)5-6-14-17(12)18-19(27-14)20(26)23-11(2)10-22-18/h3-9,11,22H,1,10H2,2H3,(H,23,26) GDOTTYIWCBDASJ-UHFFFAOYSA-N 688944 US20240190890, Compound I-164::(R)-10-methyl-3-(2-vinyl-1H-imidazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1.000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688944&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542238 504490613 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433761 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2ccc(Cl)n2)C(=O)N1 InChI=1S/C18H14ClN5OS/c1-9-8-20-16-15-10-2-5-14(24-7-6-13(19)23-24)22-11(10)3-4-12(15)26-17(16)18(25)21-9/h2-7,9,20H,8H2,1H3,(H,21,25) VPECMCKGBMPYFL-UHFFFAOYSA-N 688945 US20240190890, Compound I-165::(R)-3-(3-chloro-1H-pyrazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 81.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688945 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688945&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542350 504490614 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433762 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cnc(C)c(C=C)n2)C(=O)N1 InChI=1S/C22H19N5OS/c1-4-14-12(3)23-10-17(26-14)16-6-5-13-15(27-16)7-8-18-19(13)20-21(29-18)22(28)25-11(2)9-24-20/h4-8,10-11,24H,1,9H2,2-3H3,(H,25,28) DCSZTJUOHIUSJY-UHFFFAOYSA-N 688946 US20240190890, Compound I-166::(R)-10-methyl-3-(5-methyl-6-vinylpyrazin-2-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 181 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688946 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688946&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542267 504490615 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433763 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCC(F)(F)CC2)C(=O)N1 InChI=1S/C27H25F2N5OS/c1-3-17-12-16(13-22(32-17)34-10-8-27(28,29)9-11-34)19-5-4-18-20(33-19)6-7-21-23(18)24-25(36-21)26(35)31-15(2)14-30-24/h3-7,12-13,15,30H,1,8-11,14H2,2H3,(H,31,35) QZIBHGQOFQKSQP-UHFFFAOYSA-N 688947 US20240190890, Compound I-168::(R)-3-(2-(4,4-difluoropiperidin-1-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 260 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688947&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430103 504490616 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433764 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCOCC3)nc(c2)C#C)C(=O)N1 InChI=1S/C27H25N5O2S/c1-3-18-12-17(13-19(30-18)15-32-8-10-34-11-9-32)21-5-4-20-22(31-21)6-7-23-24(20)25-26(35-23)27(33)29-16(2)14-28-25/h1,4-7,12-13,16,28H,8-11,14-15H2,2H3,(H,29,33) USXRZOUIRFOVTO-UHFFFAOYSA-N 688948 US20240190890, Compound I-169::(R)-3-(2-ethynyl-6-(morpholinomethyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 39.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688948&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542307 504490617 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433765 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nnc2C)C#C)C(=O)N1 InChI=1S/C22H17N5OS/c1-4-13-9-15(12(3)26-27-13)17-6-5-14-16(25-17)7-8-18-19(14)20-21(29-18)22(28)24-11(2)10-23-20/h1,5-9,11,23H,10H2,2-3H3,(H,24,28) YTPQITVTXNCAQF-UHFFFAOYSA-N 688949 US20240190890, Compound I-170::(R)-3-(6-ethynyl-3-methylpyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 18.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688949 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688949&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542073 504490618 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433766 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCN(C)CC2)C(=O)N1 InChI=1S/C27H28N6OS/c1-4-18-13-17(14-23(30-18)33-11-9-32(3)10-12-33)20-6-5-19-21(31-20)7-8-22-24(19)25-26(35-22)27(34)29-16(2)15-28-25/h4-8,13-14,16,28H,1,9-12,15H2,2-3H3,(H,29,34) SKVCMCBKRCIKAY-UHFFFAOYSA-N 688876 US20240190890, Compound I-96::US20240190890, Compound I-171::(R)-10-methyl-3-(2-(4-methylpiperazin-1-yl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688876 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688876&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430075 504490546 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433767 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CCN(C)CC2)C#C)C(=O)N1 InChI=1S/C27H26N6OS/c1-4-18-13-17(14-23(30-18)33-11-9-32(3)10-12-33)20-6-5-19-21(31-20)7-8-22-24(19)25-26(35-22)27(34)29-16(2)15-28-25/h1,5-8,13-14,16,28H,9-12,15H2,2-3H3,(H,29,34) WNOGJJHITUPYLM-UHFFFAOYSA-N 688875 US20240190890, Compound I-172::(R)-3-(2-ethynyl-6-(4-methylpiperazin-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-95 MAP kinase-activated protein kinase 2 Homo sapiens 97.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688875 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688875&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430074 504490545 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433768 CCN1CCN(CC1)c1cc(cc(C=C)n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C28H30N6OS/c1-4-19-14-18(15-24(31-19)34-12-10-33(5-2)11-13-34)21-7-6-20-22(32-21)8-9-23-25(20)26-27(36-23)28(35)30-17(3)16-29-26/h4,6-9,14-15,17,29H,1,5,10-13,16H2,2-3H3,(H,30,35) CGFSHUFEMKLMRW-UHFFFAOYSA-N 688952 US20240190890, Compound I-173::(R)-3-(2-(4-ethylpiperazin-1-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 35.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688952 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688952&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430104 504490619 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433769 CCN1CCN(CC1)c1cc(cc(n1)C#C)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C28H28N6OS/c1-4-19-14-18(15-24(31-19)34-12-10-33(5-2)11-13-34)21-7-6-20-22(32-21)8-9-23-25(20)26-27(36-23)28(35)30-17(3)16-29-26/h1,6-9,14-15,17,29H,5,10-13,16H2,2-3H3,(H,30,35) ZOZYMPWQADGQEW-UHFFFAOYSA-N 688953 US20240190890, Compound I-174::(R)-3-(2-(4-ethylpiperazin-1-yl)-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 98.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688953 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688953&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430105 504490620 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433770 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCNCC2)C(=O)N1 InChI=1S/C26H26N6OS/c1-3-17-12-16(13-22(30-17)32-10-8-27-9-11-32)19-5-4-18-20(31-19)6-7-21-23(18)24-25(34-21)26(33)29-15(2)14-28-24/h3-7,12-13,15,27-28H,1,8-11,14H2,2H3,(H,29,33) ILDTUYKXNHTPFK-UHFFFAOYSA-N 688954 US20240190890, Compound I-175::(R)-10-methyl-3-(2-(piperazin-1-yl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 10.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688954 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688954&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542396 504490621 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433771 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CCNCC2)C#C)C(=O)N1 InChI=1S/C26H24N6OS/c1-3-17-12-16(13-22(30-17)32-10-8-27-9-11-32)19-5-4-18-20(31-19)6-7-21-23(18)24-25(34-21)26(33)29-15(2)14-28-24/h1,4-7,12-13,15,27-28H,8-11,14H2,2H3,(H,29,33) AKJGETYOYAYORZ-UHFFFAOYSA-N 688955 US20240190890, Compound I-176::(R)-3-(2-ethynyl-6-(piperazin-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 70.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688955 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688955&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541915 504490622 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433772 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCCCC2)C(=O)N1 InChI=1S/C27H27N5OS/c1-3-18-13-17(14-23(30-18)32-11-5-4-6-12-32)20-8-7-19-21(31-20)9-10-22-24(19)25-26(34-22)27(33)29-16(2)15-28-25/h3,7-10,13-14,16,28H,1,4-6,11-12,15H2,2H3,(H,29,33) WLOZPARFWLDYFS-UHFFFAOYSA-N 688956 US20240190890, Compound I-177::(R)-10-methyl-3-(2-(piperidin-1-yl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 140 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688956&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542351 504490623 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433773 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CCCCC2)C#C)C(=O)N1 InChI=1S/C27H25N5OS/c1-3-18-13-17(14-23(30-18)32-11-5-4-6-12-32)20-8-7-19-21(31-20)9-10-22-24(19)25-26(34-22)27(33)29-16(2)15-28-25/h1,7-10,13-14,16,28H,4-6,11-12,15H2,2H3,(H,29,33) UUROORGNZGHBTC-UHFFFAOYSA-N 688957 US20240190890, Compound I-178::(R)-3-(2-ethynyl-6-(piperidin-1-yl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 185 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688957 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688957&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542111 504490624 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433774 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCC2)C(=O)N1 InChI=1S/C25H23N5OS/c1-3-16-11-15(12-21(28-16)30-9-4-10-30)18-6-5-17-19(29-18)7-8-20-22(17)23-24(32-20)25(31)27-14(2)13-26-23/h3,5-8,11-12,14,26H,1,4,9-10,13H2,2H3,(H,27,31) IVOMDRORAAAKBZ-UHFFFAOYSA-N 688958 US20240190890, Compound I-179::(R)-3-(2-(azetidin-1-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 11.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688958 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688958&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541973 504490625 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433775 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CCC2)C#C)C(=O)N1 InChI=1S/C25H21N5OS/c1-3-16-11-15(12-21(28-16)30-9-4-10-30)18-6-5-17-19(29-18)7-8-20-22(17)23-24(32-20)25(31)27-14(2)13-26-23/h1,5-8,11-12,14,26H,4,9-10,13H2,2H3,(H,27,31) OZDNPRSZRWQZPY-UHFFFAOYSA-N 688959 US20240190890, Compound I-180::(R)-3-(2-(azetidin-1-yl)-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 184 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688959&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542370 504490626 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433776 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)cnc2C)C(=O)N1 InChI=1S/C22H19N5OS/c1-4-13-10-23-12(3)19(26-13)16-6-5-14-15(27-16)7-8-17-18(14)20-21(29-17)22(28)25-11(2)9-24-20/h4-8,10-11,24H,1,9H2,2-3H3,(H,25,28) JUZZGBPNGCMSBZ-UHFFFAOYSA-N 688960 US20240190890, Compound I-181::(R)-10-methyl-3-(3-methyl-6-vinylpyrazin-2-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 39.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688960&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542125 504490627 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433777 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CCC(F)(F)CC2)C#C)C(=O)N1 InChI=1S/C27H23F2N5OS/c1-3-17-12-16(13-22(32-17)34-10-8-27(28,29)9-11-34)19-5-4-18-20(33-19)6-7-21-23(18)24-25(36-21)26(35)31-15(2)14-30-24/h1,4-7,12-13,15,30H,8-11,14H2,2H3,(H,31,35) RNQFLBCTCIVJLM-UHFFFAOYSA-N 688961 US20240190890, Compound I-182::(R)-3-(2-(4,4-difluoropiperidin-1-yl)-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688961 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688961&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430106 504490628 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433778 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(nc(c2)N2CC(F)(F)C2)C#C)C(=O)N1 InChI=1S/C25H19F2N5OS/c1-3-15-8-14(9-20(30-15)32-11-25(26,27)12-32)17-5-4-16-18(31-17)6-7-19-21(16)22-23(34-19)24(33)29-13(2)10-28-22/h1,4-9,13,28H,10-12H2,2H3,(H,29,33) NDUPJRURTAQADU-UHFFFAOYSA-N 688962 US20240190890, Compound I-183::(R)-3-(2-(3,3-difluoroazetidin-1-yl)-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 839 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688962&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430107 504490629 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433779 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CC(F)(F)C2)C(=O)N1 InChI=1S/C25H21F2N5OS/c1-3-15-8-14(9-20(30-15)32-11-25(26,27)12-32)17-5-4-16-18(31-17)6-7-19-21(16)22-23(34-19)24(33)29-13(2)10-28-22/h3-9,13,28H,1,10-12H2,2H3,(H,29,33) AAVYEFCJYLTJPU-UHFFFAOYSA-N 688963 US20240190890, Compound I-184::(R)-3-(2-(3,3-difluoroazetidin-1-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 175 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688963 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688963&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430108 504490630 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433780 C[C@H]1CN(Cc2cc(cc(C=C)n2)-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)C[C@@H](C)O1 InChI=1S/C29H31N5O2S/c1-5-20-10-19(11-21(32-20)15-34-13-17(3)36-18(4)14-34)23-7-6-22-24(33-23)8-9-25-26(22)27-28(37-25)29(35)31-16(2)12-30-27/h5-11,16-18,30H,1,12-15H2,2-4H3,(H,31,35) OBWCIORHCHPDPA-UHFFFAOYSA-N 688964 US20240190890, Compound I-185::(R)-3-(2-(((2S,6R)-2,6-dimethylmorpholino)methyl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 7.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688964 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688964&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171723532 504490631 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433781 C[C@H]1CN(Cc2cc(cc(n2)C#C)-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)C[C@@H](C)O1 InChI=1S/C29H29N5O2S/c1-5-20-10-19(11-21(32-20)15-34-13-17(3)36-18(4)14-34)23-7-6-22-24(33-23)8-9-25-26(22)27-28(37-25)29(35)31-16(2)12-30-27/h1,6-11,16-18,30H,12-15H2,2-4H3,(H,31,35) YEWAPTIJMWRJSN-UHFFFAOYSA-N 688965 US20240190890, Compound I-186::(R)-3-(2-(((2S,6R)-2,6-dimethylmorpholino)methyl)-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 26.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688965&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171723399 504490632 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433782 C[C@@H]1CN(Cc2cc(cc(C=C)n2)-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)C[C@@H](C)O1 InChI=1S/C29H31N5O2S/c1-5-20-10-19(11-21(32-20)15-34-13-17(3)36-18(4)14-34)23-7-6-22-24(33-23)8-9-25-26(22)27-28(37-25)29(35)31-16(2)12-30-27/h5-11,16-18,30H,1,12-15H2,2-4H3,(H,31,35) OBWCIORHCHPDPA-UHFFFAOYSA-N 688966 US20240190890, Compound I-187::(R)-3-(2-(((2R,6R)-2,6-dimethylmorpholino)methyl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 8.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688966&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171723494 504490633 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433783 C[C@@H]1CN(Cc2cc(cc(n2)C#C)-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)C[C@@H](C)O1 InChI=1S/C29H29N5O2S/c1-5-20-10-19(11-21(32-20)15-34-13-17(3)36-18(4)14-34)23-7-6-22-24(33-23)8-9-25-26(22)27-28(37-25)29(35)31-16(2)12-30-27/h1,6-11,16-18,30H,12-15H2,2-4H3,(H,31,35) YEWAPTIJMWRJSN-UHFFFAOYSA-N 688967 US20240190890, Compound I-188::(R)-3-(2-(((2R,6R)-2,6-dimethylmorpholino)methyl)-6-ethynylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 25.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688967 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688967&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430109 504490634 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433784 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCC(CC3)OC(F)(F)F)nc(C=C)c2)C(=O)N1 InChI=1S/C29H28F3N5O2S/c1-3-18-12-17(13-19(35-18)15-37-10-8-20(9-11-37)39-29(30,31)32)22-5-4-21-23(36-22)6-7-24-25(21)26-27(40-24)28(38)34-16(2)14-33-26/h3-7,12-13,16,20,33H,1,8-11,14-15H2,2H3,(H,34,38) VKUJPDZXUJUFRS-UHFFFAOYSA-N 688968 US20240190890, Compound I-189::(R)-10-methyl-3-(2-((4-(trifluoromethoxy)piperidin-1-yl)methyl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 206 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688968 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688968&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430110 504490635 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433785 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CN3CCC(CC3)OC(F)(F)F)nc(c2)C#C)C(=O)N1 InChI=1S/C29H26F3N5O2S/c1-3-18-12-17(13-19(35-18)15-37-10-8-20(9-11-37)39-29(30,31)32)22-5-4-21-23(36-22)6-7-24-25(21)26-27(40-24)28(38)34-16(2)14-33-26/h1,4-7,12-13,16,20,33H,8-11,14-15H2,2H3,(H,34,38) ILWWQBCBTJKXOG-UHFFFAOYSA-N 688969 US20240190890, Compound I-190::(R)-3-(2-ethynyl-6-((4-(trifluoromethoxy)piperidin-1-yl)methyl)pyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 402 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688969&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430111 504490636 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433786 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)nc3CCN(C)Cc23)C(=O)N1 InChI=1S/C25H24N6OS/c1-4-20-29-17-9-10-31(3)12-15(17)22(30-20)18-6-5-14-16(28-18)7-8-19-21(14)23-24(33-19)25(32)27-13(2)11-26-23/h4-8,13,26H,1,9-12H2,2-3H3,(H,27,32) ANHKDEKAGRYWCB-UHFFFAOYSA-N 688970 US20240190890, Compound I-191::(R)-10-methyl-3-(6-methyl-2-vinyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 289 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688970 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688970&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430112 504490637 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433787 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)nc3CCN(C)Cc23)C(=O)N1 InChI=1S/C23H21ClN6OS/c1-11-9-25-20-18-12-3-4-16(19-13-10-30(2)8-7-15(13)28-23(24)29-19)27-14(12)5-6-17(18)32-21(20)22(31)26-11/h3-6,11,25H,7-10H2,1-2H3,(H,26,31) RHZGPUZQAKUGDH-UHFFFAOYSA-N 688971 US20240190890, Compound I-192::(R)-3-(2-chloro-6-methyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 257 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688971 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688971&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430113 504490638 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433788 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(nc3CCN(C)Cc23)C#C)C(=O)N1 InChI=1S/C25H22N6OS/c1-4-20-29-17-9-10-31(3)12-15(17)22(30-20)18-6-5-14-16(28-18)7-8-19-21(14)23-24(33-19)25(32)27-13(2)11-26-23/h1,5-8,13,26H,9-12H2,2-3H3,(H,27,32) GNVVOGGATFLMJL-UHFFFAOYSA-N 688972 US20240190890, Compound I-193::(R)-3-(2-ethynyl-6-methyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 526 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688972&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430114 504490639 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433789 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(C)c2C)C(=O)N1 InChI=1S/C24H22N4OS/c1-5-15-10-17(13(3)14(4)27-15)19-7-6-16-18(28-19)8-9-20-21(16)22-23(30-20)24(29)26-12(2)11-25-22/h5-10,12,25H,1,11H2,2-4H3,(H,26,29) IOUCBHGBHNDCHX-UHFFFAOYSA-N 688973 US20240190890, Compound I-194::(R)-3-(2,3-dimethyl-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 5.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688973 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688973&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541939 504490640 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433790 CCc1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H22N4OS/c1-4-14-12-25-15(5-2)10-17(14)19-7-6-16-18(28-19)8-9-20-21(16)22-23(30-20)24(29)27-13(3)11-26-22/h5-10,12-13,26H,2,4,11H2,1,3H3,(H,27,29) LUIYQCQCXBDIJY-UHFFFAOYSA-N 688974 US20240190890, Compound I-195::(R)-3-(5-ethyl-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688974 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688974&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542086 504490641 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433791 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2C2CC2)C(=O)N1 InChI=1S/C25H22N4OS/c1-3-15-10-17(18(12-26-15)14-4-5-14)20-7-6-16-19(29-20)8-9-21-22(16)23-24(31-21)25(30)28-13(2)11-27-23/h3,6-10,12-14,27H,1,4-5,11H2,2H3,(H,28,30) DEODQQWVBZLXPI-UHFFFAOYSA-N 688975 US20240190890, Compound I-196::(R)-3-(5-cyclopropyl-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 5.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688975 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688975&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542324 504490642 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433792 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(CN3CCOCC3)c2C)C(=O)N1 InChI=1S/C28H29N5O2S/c1-4-18-13-20(17(3)23(31-18)15-33-9-11-35-12-10-33)22-6-5-19-21(32-22)7-8-24-25(19)26-27(36-24)28(34)30-16(2)14-29-26/h4-8,13,16,29H,1,9-12,14-15H2,2-3H3,(H,30,34) WZSXICVKZNTBRR-UHFFFAOYSA-N 688976 US20240190890, Compound I-197::(R)-10-methyl-3-(3-methyl-2-(morpholinomethyl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 5.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688976&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430115 504490643 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433793 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(CN3CCOCC3)c2F)C(=O)N1 InChI=1S/C27H26FN5O2S/c1-3-16-12-18(24(28)21(31-16)14-33-8-10-35-11-9-33)20-5-4-17-19(32-20)6-7-22-23(17)25-26(36-22)27(34)30-15(2)13-29-25/h3-7,12,15,29H,1,8-11,13-14H2,2H3,(H,30,34) LJHFRSVTIZPUPW-UHFFFAOYSA-N 688977 US20240190890, Compound I-198::(R)-3-(3-fluoro-2-(morpholinomethyl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 106 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688977 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688977&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542358 504490644 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433794 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(\C=C\C(F)(F)F)c2)C(=O)N1 InChI=1S/C23H17F3N4OS/c1-12-11-28-20-19-15-2-3-16(13-7-9-27-14(10-13)6-8-23(24,25)26)30-17(15)4-5-18(19)32-21(20)22(31)29-12/h2-10,12,28H,11H2,1H3,(H,29,31) YXOPJQJMANNZIN-UHFFFAOYSA-N 688978 US20240190890, Compound I-199::(R,E)-10-methyl-3-(2-(3,3,3-trifluoroprop-1-en-1-yl)pyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 636 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688978 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688978&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430116 504490645 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433795 COc1nnc(\C=C\C(F)(F)F)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C23H18F3N5O2S/c1-11-10-27-19-18-13-3-4-16(29-15(13)5-6-17(18)34-20(19)21(32)28-11)14-9-12(7-8-23(24,25)26)30-31-22(14)33-2/h3-9,11,27H,10H2,1-2H3,(H,28,32) XDFJMHAEAZCCGR-UHFFFAOYSA-N 688979 US20240190890, Compound I-200::(R,E)-3-(3-methoxy-6-(3,3,3-trifluoroprop-1-en-1-yl)pyridazin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688979 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688979&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430117 504490646 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433796 CC1CN(CC(C)O1)c1cc(cc(C=C)n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C28H29N5O2S/c1-5-19-10-18(11-24(31-19)33-13-16(3)35-17(4)14-33)21-7-6-20-22(32-21)8-9-23-25(20)26-27(36-23)28(34)30-15(2)12-29-26/h5-11,15-17,29H,1,12-14H2,2-4H3,(H,30,34) VCVUNZBNQDDTPL-UHFFFAOYSA-N 688980 US20240190890, Compound I-201::(10R)-3-(2-(2,6-dimethylmorpholino)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 73.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688980 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688980&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430118 504490647 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433797 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCC(CC2)C(F)(F)F)C(=O)N1 InChI=1S/C28H26F3N5OS/c1-3-18-12-16(13-23(34-18)36-10-8-17(9-11-36)28(29,30)31)20-5-4-19-21(35-20)6-7-22-24(19)25-26(38-22)27(37)33-15(2)14-32-25/h3-7,12-13,15,17,32H,1,8-11,14H2,2H3,(H,33,37) ZDIUGIUAQKVSJL-UHFFFAOYSA-N 688981 US20240190890, Compound I-202::(R)-10-methyl-3-(2-(4-(trifluoromethyl)piperidin-1-yl)-6-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 674 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688981 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688981&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430119 504490648 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433798 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2cnnc2C=C)C(=O)N1 InChI=1S/C19H16N6OS/c1-3-14-24-21-9-25(14)15-7-4-11-12(23-15)5-6-13-16(11)17-18(27-13)19(26)22-10(2)8-20-17/h3-7,9-10,20H,1,8H2,2H3,(H,22,26) XHPLWICZTMVVSM-UHFFFAOYSA-N 688982 US20240190890, Compound I-203::(R)-10-methyl-3-(3-vinyl-4H-1,2,4-triazol-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 9.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688982 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688982&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542106 504490649 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433799 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2cnnc2C#C)C(=O)N1 InChI=1S/C19H14N6OS/c1-3-14-24-21-9-25(14)15-7-4-11-12(23-15)5-6-13-16(11)17-18(27-13)19(26)22-10(2)8-20-17/h1,4-7,9-10,20H,8H2,2H3,(H,22,26) MISUSVXJPXSDHX-UHFFFAOYSA-N 688983 US20240190890, Compound I-204::(R)-3-(3-ethynyl-4H-1,2,4-triazol-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 555 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688983 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688983&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542362 504490650 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433800 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2ccnc2Cl)C(=O)N1 InChI=1S/C18H14ClN5OS/c1-9-8-21-15-14-10-2-5-13(24-7-6-20-18(24)19)23-11(10)3-4-12(14)26-16(15)17(25)22-9/h2-7,9,21H,8H2,1H3,(H,22,25) LAVPUEOHZHZXHL-UHFFFAOYSA-N 688984 US20240190890, Compound I-205::(R)-3-(2-chloro-1H-imidazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 97.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688984 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688984&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541893 504490651 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433801 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2cc(C)nc2C=C)C(=O)N1 InChI=1S/C21H19N5OS/c1-4-16-23-12(3)10-26(16)17-8-5-13-14(25-17)6-7-15-18(13)19-20(28-15)21(27)24-11(2)9-22-19/h4-8,10-11,22H,1,9H2,2-3H3,(H,24,27) XVMDXYYSTFZQTH-UHFFFAOYSA-N 688985 US20240190890, Compound I-206::(R)-10-methyl-3-(4-methyl-2-vinyl-1H-imidazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688985 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688985&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542026 504490652 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433802 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2cnc(C=C)n2)C(=O)N1 InChI=1S/C19H16N6OS/c1-3-14-21-9-25(24-14)15-7-4-11-12(23-15)5-6-13-16(11)17-18(27-13)19(26)22-10(2)8-20-17/h3-7,9-10,20H,1,8H2,2H3,(H,22,26) PBRQYJZUSAFOSL-UHFFFAOYSA-N 688986 US20240190890, Compound I-207::(R)-10-methyl-3-(3-vinyl-1H-1,2,4-triazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 26.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688986&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542281 504490653 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433803 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(C=C)n(C)n2)C(=O)N1 InChI=1S/C20H18N6OS/c1-4-15-24-19(25-26(15)3)13-6-5-11-12(23-13)7-8-14-16(11)17-18(28-14)20(27)22-10(2)9-21-17/h4-8,10,21H,1,9H2,2-3H3,(H,22,27) ZSCSLCKMRFAWJW-UHFFFAOYSA-N 688987 US20240190890, Compound I-208::(R)-10-methyl-3-(1-methyl-5-vinyl-1H-1,2,4-triazol-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 285 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688987 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688987&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541926 504490654 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433804 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cnc(C=C)s2)C(=O)N1 InChI=1S/C20H16N4OS2/c1-3-16-21-9-15(26-16)13-5-4-11-12(24-13)6-7-14-17(11)18-19(27-14)20(25)23-10(2)8-22-18/h3-7,9-10,22H,1,8H2,2H3,(H,23,25) YXQRQGBIXITQKS-UHFFFAOYSA-N 688988 US20240190890, Compound I-209::(R)-10-methyl-3-(2-vinylthiazol-5-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 15.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688988 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688988&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542043 504490655 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433805 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2cnc(Cl)n2)C(=O)N1 InChI=1S/C17H13ClN6OS/c1-8-6-19-14-13-9-2-5-12(24-7-20-17(18)23-24)22-10(9)3-4-11(13)26-15(14)16(25)21-8/h2-5,7-8,19H,6H2,1H3,(H,21,25) CVUUBBVPJBBIAA-UHFFFAOYSA-N 688989 US20240190890, Compound I-210::(R)-3-(3-chloro-1H-1,2,4-triazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 91.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688989&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541953 504490656 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433806 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2CN2CC(F)(F)C2)C(=O)N1 InChI=1S/C26H23F2N5OS/c1-3-16-8-18(15(10-29-16)11-33-12-26(27,28)13-33)20-5-4-17-19(32-20)6-7-21-22(17)23-24(35-21)25(34)31-14(2)9-30-23/h3-8,10,14,30H,1,9,11-13H2,2H3,(H,31,34) MCERVZUXHAZFRL-UHFFFAOYSA-N 688990 US20240190890, Compound I-211::(R)-3-(5-((3,3-difluoroazetidin-1-yl)methyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 275 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688990 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688990&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430120 504490657 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433807 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2CN2CCC(CC2)C(F)(F)F)C(=O)N1 InChI=1S/C29H28F3N5OS/c1-3-19-12-21(17(14-33-19)15-37-10-8-18(9-11-37)29(30,31)32)23-5-4-20-22(36-23)6-7-24-25(20)26-27(39-24)28(38)35-16(2)13-34-26/h3-7,12,14,16,18,34H,1,8-11,13,15H2,2H3,(H,35,38) SSFNJUJYWWRSBQ-UHFFFAOYSA-N 688991 US20240190890, Compound I-212::(R)-10-methyl-3-(5-((4-(trifluoromethyl)piperidin-1-yl)methyl)-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 92.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688991 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688991&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430121 504490658 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433808 C[C@H]1CN(Cc2cnc(C=C)cc2-c2ccc3c4c5NC[C@@H](C)NC(=O)c5sc4ccc3n2)C[C@@H](C)O1 InChI=1S/C29H31N5O2S/c1-5-20-10-22(19(12-30-20)15-34-13-17(3)36-18(4)14-34)24-7-6-21-23(33-24)8-9-25-26(21)27-28(37-25)29(35)32-16(2)11-31-27/h5-10,12,16-18,31H,1,11,13-15H2,2-4H3,(H,32,35) MIHWKVZJXVWLBK-UHFFFAOYSA-N 688992 US20240190890, Compound I-213::(R)-3-(5-(((2S,6R)-2,6-dimethylmorpholino)methyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 103 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688992 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688992&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430122 504490659 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433809 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2ncnc2C=C)C(=O)N1 InChI=1S/C19H16N6OS/c1-3-14-21-9-22-25(14)15-7-4-11-12(24-15)5-6-13-16(11)17-18(27-13)19(26)23-10(2)8-20-17/h3-7,9-10,20H,1,8H2,2H3,(H,23,26) KTARDXLFOUDLII-UHFFFAOYSA-N 688993 US20240190890, Compound I-214::(R)-10-methyl-3-(5-vinyl-1H-1,2,4-triazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688993 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688993&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541960 504490660 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433810 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCC3(CCC(=O)O3)CC2)C(=O)N1 |r| InChI=1S/C30H29N5O3S/c1-3-19-14-18(15-24(33-19)35-12-10-30(11-13-35)9-8-25(36)38-30)21-5-4-20-22(34-21)6-7-23-26(20)27-28(39-23)29(37)32-17(2)16-31-27/h3-7,14-15,17,31H,1,8-13,16H2,2H3,(H,32,37) KQJGVWLJDNPNKM-UHFFFAOYSA-N 688994 US20240190890, Compound I-215::rac-(R)-8-(4-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)-6-vinylpyridin-2-yl)-1-oxa-8-azaspiro[4.5]decan-2-one MAP kinase-activated protein kinase 2 Homo sapiens 21.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688994 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688994&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430123 504490661 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433811 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CC3CC2CO3)C(=O)N1 |r| InChI=1S/C27H25N5O2S/c1-3-16-8-15(9-23(30-16)32-12-18-10-17(32)13-34-18)20-5-4-19-21(31-20)6-7-22-24(19)25-26(35-22)27(33)29-14(2)11-28-25/h3-9,14,17-18,28H,1,10-13H2,2H3,(H,29,33) UAUDQYZVWMPVJD-UHFFFAOYSA-N 688995 US20240190890, Compound I-216::rac-(10R)-3-(2-(2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 11.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688995 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688995&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430124 504490662 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433812 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(C=C)c2F)C(=O)N1 InChI=1S/C22H17FN4OS/c1-3-14-19(23)13(8-9-24-14)16-5-4-12-15(27-16)6-7-17-18(12)20-21(29-17)22(28)26-11(2)10-25-20/h3-9,11,25H,1,10H2,2H3,(H,26,28) YRFPAEXAHRVQAJ-UHFFFAOYSA-N 688996 US20240190890, Compound I-217::(R)-3-(3-fluoro-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 78.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688996 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688996&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542304 504490663 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433813 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(C#C)c2F)C(=O)N1 InChI=1S/C22H15FN4OS/c1-3-14-19(23)13(8-9-24-14)16-5-4-12-15(27-16)6-7-17-18(12)20-21(29-17)22(28)26-11(2)10-25-20/h1,4-9,11,25H,10H2,2H3,(H,26,28) KBWOMRYXMQGXKZ-UHFFFAOYSA-N 688997 US20240190890, Compound I-218::(R)-3-(2-ethynyl-3-fluoropyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 79.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688997 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688997&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541891 504490664 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433814 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(C=C)c2C)C(=O)N1 InChI=1S/C23H20N4OS/c1-4-16-13(3)14(9-10-24-16)17-6-5-15-18(27-17)7-8-19-20(15)21-22(29-19)23(28)26-12(2)11-25-21/h4-10,12,25H,1,11H2,2-3H3,(H,26,28) VXLLOQZNXCQVKJ-UHFFFAOYSA-N 688998 US20240190890, Compound I-219::(R)-10-methyl-3-(3-methyl-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 142 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688998 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688998&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542371 504490665 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433815 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(C#C)c2C)C(=O)N1 InChI=1S/C23H18N4OS/c1-4-16-13(3)14(9-10-24-16)17-6-5-15-18(27-17)7-8-19-20(15)21-22(29-19)23(28)26-12(2)11-25-21/h1,5-10,12,25H,11H2,2-3H3,(H,26,28) CIFRNJAUIKCJJY-UHFFFAOYSA-N 688999 US20240190890, Compound I-220::(R)-3-(2-ethynyl-3-methylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 177 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688999 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688999&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542024 504490666 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433816 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(Cl)c2F)C(=O)N1 InChI=1S/C20H14ClFN4OS/c1-9-8-24-17-15-10-2-3-13(11-6-7-23-19(21)16(11)22)26-12(10)4-5-14(15)28-18(17)20(27)25-9/h2-7,9,24H,8H2,1H3,(H,25,27) GUAWBFMSCCGCHD-UHFFFAOYSA-N 689000 US20240190890, Compound I-221::(R)-3-(2-chloro-3-fluoropyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 212 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689000 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689000&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542005 504490667 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433817 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2c(C)nnc2C=C)C(=O)N1 InChI=1S/C20H18N6OS/c1-4-15-25-24-11(3)26(15)16-8-5-12-13(23-16)6-7-14-17(12)18-19(28-14)20(27)22-10(2)9-21-18/h4-8,10,21H,1,9H2,2-3H3,(H,22,27) UKZIWSCAZRXXEI-UHFFFAOYSA-N 689001 US20240190890, Compound I-223::(R)-10-methyl-3-(3-methyl-5-vinyl-4H-1,2,4-triazol-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689001 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689001&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542390 504490668 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433818 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2nc(C)nc2C=C)C(=O)N1 InChI=1S/C20H18N6OS/c1-4-15-23-11(3)25-26(15)16-8-5-12-13(24-16)6-7-14-17(12)18-19(28-14)20(27)22-10(2)9-21-18/h4-8,10,21H,1,9H2,2-3H3,(H,22,27) VUTLURZCMHNLEM-UHFFFAOYSA-N 689002 US20240190890, Compound I-224::(R)-10-methyl-3-(3-methyl-5-vinyl-1H-1,2,4-triazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 2.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689002 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689002&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542386 504490669 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433819 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cncc(n2)C(=C)C(F)(F)F)C(=O)N1 InChI=1S/C22H16F3N5OS/c1-10-7-27-19-18-12-3-4-14(16-9-26-8-15(30-16)11(2)22(23,24)25)29-13(12)5-6-17(18)32-20(19)21(31)28-10/h3-6,8-10,27H,2,7H2,1H3,(H,28,31) RJKNHNIUOBIRNC-UHFFFAOYSA-N 689003 US20240190890, Compound I-225::(R)-10-methyl-3-(6-(3,3,3-trifluoroprop-1-en-2-yl)pyrazin-2-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 19.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689003&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430125 504490670 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433820 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2nc(nc2C=C)C(F)(F)F)C(=O)N1 InChI=1S/C20H15F3N6OS/c1-3-13-27-19(20(21,22)23)28-29(13)14-7-4-10-11(26-14)5-6-12-15(10)16-17(31-12)18(30)25-9(2)8-24-16/h3-7,9,24H,1,8H2,2H3,(H,25,30) BOXZFQDKAUZSHQ-UHFFFAOYSA-N 689004 US20240190890, Compound I-226::(R)-10-methyl-3-(3-(trifluoromethyl)-5-vinyl-1H-1,2,4-triazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 7.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689004 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689004&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430126 504490671 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433821 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2c(C)onc2C=C)C(=O)N1 InChI=1S/C21H18N4O2S/c1-4-13-17(11(3)27-25-13)15-6-5-12-14(24-15)7-8-16-18(12)19-20(28-16)21(26)23-10(2)9-22-19/h4-8,10,22H,1,9H2,2-3H3,(H,23,26) GFIPJSOTFOBQQO-UHFFFAOYSA-N 689005 US20240190890, Compound I-227::(R)-10-methyl-3-(5-methyl-3-vinylisoxazol-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 418 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689005&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542247 504490672 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433822 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2csnc2C=C)C(=O)N1 InChI=1S/C20H16N4OS2/c1-3-13-12(9-26-24-13)15-5-4-11-14(23-15)6-7-16-17(11)18-19(27-16)20(25)22-10(2)8-21-18/h3-7,9-10,21H,1,8H2,2H3,(H,22,25) YROLAJRIDRCTHN-UHFFFAOYSA-N 689006 US20240190890, Compound I-228::(R)-10-methyl-3-(3-vinylisothiazol-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 128 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689006 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689006&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541881 504490673 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433823 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cnsc2C=C)C(=O)N1 InChI=1S/C20H16N4OS2/c1-3-15-12(9-22-27-15)14-5-4-11-13(24-14)6-7-16-17(11)18-19(26-16)20(25)23-10(2)8-21-18/h3-7,9-10,21H,1,8H2,2H3,(H,23,25) FWJPLVJMCVPIIM-UHFFFAOYSA-N 689007 US20240190890, Compound I-229::(R)-10-methyl-3-(5-vinylisothiazol-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 123 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689007 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689007&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542123 504490674 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433824 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cn(C)nc2C=C)C(=O)N1 InChI=1S/C21H19N5OS/c1-4-14-13(10-26(3)25-14)16-6-5-12-15(24-16)7-8-17-18(12)19-20(28-17)21(27)23-11(2)9-22-19/h4-8,10-11,22H,1,9H2,2-3H3,(H,23,27) ZDMAZGAXWIRRFZ-UHFFFAOYSA-N 689008 US20240190890, Compound I-230::(R)-10-methyl-3-(1-methyl-3-vinyl-1H-pyrazol-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 44.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689008 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689008&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542306 504490675 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433825 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2c(C)c(C)nc2C=C)C(=O)N1 InChI=1S/C22H21N5OS/c1-5-17-25-12(3)13(4)27(17)18-9-6-14-15(26-18)7-8-16-19(14)20-21(29-16)22(28)24-11(2)10-23-20/h5-9,11,23H,1,10H2,2-4H3,(H,24,28) OFISPFUCPAUNPH-UHFFFAOYSA-N 689009 US20240190890, Compound I-231::(R)-3-(4,5-dimethyl-2-vinyl-1H-imidazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 28.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689009 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689009&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541899 504490676 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433826 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nn(C)nc2C=C)C(=O)N1 InChI=1S/C20H18N6OS/c1-4-12-17(25-26(3)24-12)14-6-5-11-13(23-14)7-8-15-16(11)18-19(28-15)20(27)22-10(2)9-21-18/h4-8,10,21H,1,9H2,2-3H3,(H,22,27) PFEDHUGTYWLHKM-UHFFFAOYSA-N 689010 US20240190890, Compound I-232::(R)-10-methyl-3-(2-methyl-5-vinyl-2H-1,2,3-triazol-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 77.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689010&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542316 504490677 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433827 CCOC(=O)c1nc(C=C)sc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C23H20N4O3S2/c1-4-16-27-19(23(29)30-5-2)20(32-16)14-7-6-12-13(26-14)8-9-15-17(12)18-21(31-15)22(28)25-11(3)10-24-18/h4,6-9,11,24H,1,5,10H2,2-3H3,(H,25,28) UQIHHBRHOCFGJA-UHFFFAOYSA-N 689011 US20240190890, Compound I-234::ethyl (R)-5-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)-2-vinylthiazole-4-carboxylate MAP kinase-activated protein kinase 2 Homo sapiens 18.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689011&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430127 504490678 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433828 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2nc(C)cc2C=C)C(=O)N1 InChI=1S/C21H19N5OS/c1-4-13-9-11(2)25-26(13)17-8-5-14-15(24-17)6-7-16-18(14)19-20(28-16)21(27)23-12(3)10-22-19/h4-9,12,22H,1,10H2,2-3H3,(H,23,27) DESNTIRKVMGXJP-UHFFFAOYSA-N 689012 US20240190890, Compound I-236::(R)-10-methyl-3-(3-methyl-5-vinyl-1H-pyrazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 157 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689012 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689012&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542287 504490679 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433829 COCCN(C)c1cc(cc(C=C)n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C26H27N5O2S/c1-5-17-12-16(13-22(29-17)31(3)10-11-33-4)19-7-6-18-20(30-19)8-9-21-23(18)24-25(34-21)26(32)28-15(2)14-27-24/h5-9,12-13,15,27H,1,10-11,14H2,2-4H3,(H,28,32) AUJUEFHDCSGTFS-UHFFFAOYSA-N 689013 US20240190890, Compound I-237::(R)-3-(2-((2-methoxyethyl)(methyl)amino)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 10.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689013 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689013&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430128 504490680 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433830 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CC3(COC3)C2)C(=O)N1 InChI=1S/C27H25N5O2S/c1-3-17-8-16(9-22(30-17)32-11-27(12-32)13-34-14-27)19-5-4-18-20(31-19)6-7-21-23(18)24-25(35-21)26(33)29-15(2)10-28-24/h3-9,15,28H,1,10-14H2,2H3,(H,29,33) ASURDSIOGDRSOE-UHFFFAOYSA-N 689014 US20240190890, Compound I-238::(R)-3-(2-(2-oxa-6-azaspiro[3.3]heptan-6-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 6.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689014 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689014&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430129 504490681 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433831 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)nc(c2)N2CCC(F)CC2)C(=O)N1 InChI=1S/C27H26FN5OS/c1-3-18-12-16(13-23(31-18)33-10-8-17(28)9-11-33)20-5-4-19-21(32-20)6-7-22-24(19)25-26(35-22)27(34)30-15(2)14-29-25/h3-7,12-13,15,17,29H,1,8-11,14H2,2H3,(H,30,34) OOLAHQMTYLXGOV-UHFFFAOYSA-N 689015 US20240190890, Compound I-239::(R)-3-(2-(4-fluoropiperidin-1-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 161 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689015 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689015&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430130 504490682 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433832 COCC1CCN(CC1)c1cc(cc(C=C)n1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C29H31N5O2S/c1-4-20-13-19(14-25(32-20)34-11-9-18(10-12-34)16-36-3)22-6-5-21-23(33-22)7-8-24-26(21)27-28(37-24)29(35)31-17(2)15-30-27/h4-8,13-14,17-18,30H,1,9-12,15-16H2,2-3H3,(H,31,35) IJKGBBSQAMWFCM-UHFFFAOYSA-N 689016 US20240190890, Compound I-240::(R)-3-(2-(4-(methoxymethyl)piperidin-1-yl)-6-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 107 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689016 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689016&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430131 504490683 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433833 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2nc(cc2C=C)C(F)(F)F)C(=O)N1 InChI=1S/C21H16F3N5OS/c1-3-11-8-15(21(22,23)24)28-29(11)16-7-4-12-13(27-16)5-6-14-17(12)18-19(31-14)20(30)26-10(2)9-25-18/h3-8,10,25H,1,9H2,2H3,(H,26,30) OQUFOXRXEOUVSZ-UHFFFAOYSA-N 689017 US20240190890, Compound I-241::(R)-10-methyl-3-(3-(trifluoromethyl)-5-vinyl-1H-pyrazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689017 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689017&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430132 504490684 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433834 CC(O)c1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H22N4O2S/c1-4-14-9-16(17(11-25-14)13(3)29)19-6-5-15-18(28-19)7-8-20-21(15)22-23(31-20)24(30)27-12(2)10-26-22/h4-9,11-13,26,29H,1,10H2,2-3H3,(H,27,30) VFJDQMVTKRWATQ-UHFFFAOYSA-N 689018 US20240190890, Compound I-259::US20240190890, Compound I-260::(10R)-3-(5-(1-hydroxyethyl-2,2,2-d3)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-243 MAP kinase-activated protein kinase 2 Homo sapiens 10.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689018&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430133 504490685 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433835 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2OC(F)(F)F)C(=O)N1 InChI=1S/C23H17F3N4O2S/c1-3-12-8-14(17(10-27-12)32-23(24,25)26)16-5-4-13-15(30-16)6-7-18-19(13)20-21(33-18)22(31)29-11(2)9-28-20/h3-8,10-11,28H,1,9H2,2H3,(H,29,31) XEOGGXBBCXQFGX-UHFFFAOYSA-N 689019 US20240190890, Compound I-245::(R)-10-methyl-3-(5-(trifluoromethoxy)-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 74.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689019&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542346 504490686 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433836 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2ccnc2C#N)C(=O)N1 InChI=1S/C19H14N6OS/c1-10-9-22-17-16-11-2-5-14(25-7-6-21-15(25)8-20)24-12(11)3-4-13(16)27-18(17)19(26)23-10/h2-7,10,22H,9H2,1H3,(H,23,26) LOQSQKXHEBPWDV-UHFFFAOYSA-N 689020 US20240190890, Compound I-246::(R)-1-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)-1H-imidazole-2-carbonitrile MAP kinase-activated protein kinase 2 Homo sapiens 16.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689020&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430134 504490687 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433837 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2OC(F)F)C(=O)N1 InChI=1S/C23H18F2N4O2S/c1-3-12-8-14(17(10-26-12)31-23(24)25)16-5-4-13-15(29-16)6-7-18-19(13)20-21(32-18)22(30)28-11(2)9-27-20/h3-8,10-11,23,27H,1,9H2,2H3,(H,28,30) WGMUJTDZRYAMKW-UHFFFAOYSA-N 689021 US20240190890, Compound I-247::(R)-3-(5-(difluoromethoxy)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 360 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689021&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541902 504490688 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433838 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2nc(C=C)nc2C2CC2)C(=O)N1 InChI=1S/C22H20N6OS/c1-3-16-26-21(12-4-5-12)28(27-16)17-9-6-13-14(25-17)7-8-15-18(13)19-20(30-15)22(29)24-11(2)10-23-19/h3,6-9,11-12,23H,1,4-5,10H2,2H3,(H,24,29) JJBXUBXKMQQEEZ-UHFFFAOYSA-N 689022 US20240190890, Compound I-248::(R)-3-(5-cyclopropyl-3-vinyl-1H-1,2,4-triazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 303 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689022&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430135 504490689 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433839 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2C)C(=O)N1 InChI=1S/C23H20N4OS/c1-4-14-9-16(12(2)10-24-14)18-6-5-15-17(27-18)7-8-19-20(15)21-22(29-19)23(28)26-13(3)11-25-21/h4-10,13,25H,1,11H2,2-3H3,(H,26,28) UIPAEGAJTRBGJU-UHFFFAOYSA-N 688889 US20240190890, Compound I-142::(R)-10-methyl-3-(5-methyl-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-109::US20240190890, Compound I-249 MAP kinase-activated protein kinase 2 Homo sapiens 4.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=688889 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=688889&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541925 504490559 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433840 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2c(Br)nc(Cl)c2Cl)C(=O)N1 InChI=1S/C18H12BrCl2N5OS/c1-7-6-22-13-12-8-2-5-11(26-16(21)15(20)25-18(26)19)24-9(8)3-4-10(12)28-14(13)17(27)23-7/h2-5,7,22H,6H2,1H3,(H,23,27) GVDDEQIBMJZDQH-UHFFFAOYSA-N 689024 US20240190890, Compound I-250::(R)-3-(2-bromo-4,5-dichloro-1H-imidazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 580 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689024&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542216 504490690 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433841 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2c(Cl)c(Cl)nc2C=C)C(=O)N1 InChI=1S/C20H15Cl2N5OS/c1-3-13-26-18(21)19(22)27(13)14-7-4-10-11(25-14)5-6-12-15(10)16-17(29-12)20(28)24-9(2)8-23-16/h3-7,9,23H,1,8H2,2H3,(H,24,28) CWKNACSIGSOEQY-UHFFFAOYSA-N 689025 US20240190890, Compound I-251::(R)-3-(4,5-dichloro-2-vinyl-1H-imidazol-1-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 192 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689025&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542198 504490691 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433842 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2CO)C(=O)N1 InChI=1S/C23H20N4O2S/c1-3-14-8-16(13(11-28)10-24-14)18-5-4-15-17(27-18)6-7-19-20(15)21-22(30-19)23(29)26-12(2)9-25-21/h3-8,10,12,25,28H,1,9,11H2,2H3,(H,26,29) NULHKZXNEJFIJI-UHFFFAOYSA-N 689026 US20240190890, Compound I-252::(R)-3-(5-(hydroxymethyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 5.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689026&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542237 504490692 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433843 COCc1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H22N4O2S/c1-4-15-9-17(14(11-25-15)12-30-3)19-6-5-16-18(28-19)7-8-20-21(16)22-23(31-20)24(29)27-13(2)10-26-22/h4-9,11,13,26H,1,10,12H2,2-3H3,(H,27,29) PPVBAYFMTXCFBK-UHFFFAOYSA-N 689027 US20240190890, Compound I-253::(R)-3-(5-(methoxymethyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 6.00 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689027&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542173 504490693 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433844 Cc1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](CF)NC(=O)c4sc3ccc2n1 InChI=1S/C23H19FN4OS/c1-3-13-8-16(12(2)10-25-13)18-5-4-15-17(28-18)6-7-19-20(15)21-22(30-19)23(29)27-14(9-24)11-26-21/h3-8,10,14,26H,1,9,11H2,2H3,(H,27,29) RQKOWASNNKJWNZ-UHFFFAOYSA-N 689028 US20240190890, Compound I-254::(S)-10-(fluoromethyl)-3-(5-methyl-2-vinylpyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 27.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689028&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542272 504490694 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433845 FC[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2ccnc2C=C)C(=O)N1 InChI=1S/C20H16FN5OS/c1-2-15-22-7-8-26(15)16-6-3-12-13(25-16)4-5-14-17(12)18-19(28-14)20(27)24-11(9-21)10-23-18/h2-8,11,23H,1,9-10H2,(H,24,27) RUCYWKIPKMCRTR-UHFFFAOYSA-N 689029 US20240190890, Compound I-255::(S)-10-(fluoromethyl)-3-(2-vinyl-1H-imidazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1.000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689029&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542021 504490695 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433846 COc1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C23H20N4O2S/c1-4-13-9-15(18(29-3)11-24-13)17-6-5-14-16(27-17)7-8-19-20(14)21-22(30-19)23(28)26-12(2)10-25-21/h4-9,11-12,25H,1,10H2,2-3H3,(H,26,28) YTRUKNWXEGTQQV-UHFFFAOYSA-N 689030 US20240190890, Compound I-256::(R)-3-(5-methoxy-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 20.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689030&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542330 504490696 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433847 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2nc(C=C)cc2C(F)(F)F)C(=O)N1 InChI=1S/C21H16F3N5OS/c1-3-11-8-15(21(22,23)24)29(28-11)16-7-4-12-13(27-16)5-6-14-17(12)18-19(31-14)20(30)26-10(2)9-25-18/h3-8,10,25H,1,9H2,2H3,(H,26,30) PBZXBBSSSREFEM-UHFFFAOYSA-N 689031 US20240190890, Compound I-257::(R)-10-methyl-3-(5-(trifluoromethyl)-3-vinyl-1H-pyrazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689031&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430136 504490697 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433848 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2C(C)(C)O)C(=O)N1 InChI=1S/C25H24N4O2S/c1-5-14-10-16(17(12-26-14)25(3,4)31)19-7-6-15-18(29-19)8-9-20-21(15)22-23(32-20)24(30)28-13(2)11-27-22/h5-10,12-13,27,31H,1,11H2,2-4H3,(H,28,30) LRVKCNGADNPVEK-UHFFFAOYSA-N 689032 US20240190890, Compound I-258::(R)-3-(5-(2-hydroxypropan-2-yl-1,1,1,3,3,3-d6)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689032&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430137 504490698 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433849 CC(O)c1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H22N4O2S/c1-4-14-9-16(17(11-25-14)13(3)29)19-6-5-15-18(28-19)7-8-20-21(15)22-23(31-20)24(30)27-12(2)10-26-22/h4-9,11-13,26,29H,1,10H2,2-3H3,(H,27,30) VFJDQMVTKRWATQ-UHFFFAOYSA-N 689018 US20240190890, Compound I-259::US20240190890, Compound I-260::(10R)-3-(5-(1-hydroxyethyl-2,2,2-d3)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-243 MAP kinase-activated protein kinase 2 Homo sapiens 15.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689018&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430133 504490685 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433850 CC(O)c1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H22N4O2S/c1-4-14-9-16(17(11-25-14)13(3)29)19-6-5-15-18(28-19)7-8-20-21(15)22-23(31-20)24(30)27-12(2)10-26-22/h4-9,11-13,26,29H,1,10H2,2-3H3,(H,27,30) VFJDQMVTKRWATQ-UHFFFAOYSA-N 689018 US20240190890, Compound I-259::US20240190890, Compound I-260::(10R)-3-(5-(1-hydroxyethyl-2,2,2-d3)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one::US20240190890, Compound I-243 MAP kinase-activated protein kinase 2 Homo sapiens 16.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689018&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430133 504490685 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433851 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-n2nc(C=C)nc2C)C(=O)N1 InChI=1S/C20H18N6OS/c1-4-15-23-11(3)26(25-15)16-8-5-12-13(24-16)6-7-14-17(12)18-19(28-14)20(27)22-10(2)9-21-18/h4-8,10,21H,1,9H2,2-3H3,(H,22,27) KEYVMUGYNLEQQN-UHFFFAOYSA-N 689035 US20240190890, Compound I-261::(R)-10-methyl-3-(5-methyl-3-vinyl-1H-1,2,4-triazol-1-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689035&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542336 504490699 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433852 CCOCc1cnc(C=C)cc1-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C25H24N4O2S/c1-4-16-10-18(15(12-26-16)13-31-5-2)20-7-6-17-19(29-20)8-9-21-22(17)23-24(32-21)25(30)28-14(3)11-27-23/h4,6-10,12,14,27H,1,5,11,13H2,2-3H3,(H,28,30) NGFZCKQIKUTHIO-UHFFFAOYSA-N 689036 US20240190890, Compound I-262::(R)-3-(5-(ethoxymethyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 35.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689036&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171541997 504490700 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433853 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(C=C)ncc2CN2CC3(COC3)C2)C(=O)N1 InChI=1S/C28H27N5O2S/c1-3-18-8-20(17(10-29-18)11-33-12-28(13-33)14-35-15-28)22-5-4-19-21(32-22)6-7-23-24(19)25-26(36-23)27(34)31-16(2)9-30-25/h3-8,10,16,30H,1,9,11-15H2,2H3,(H,31,34) LUJWAYPDJMBJRZ-UHFFFAOYSA-N 689037 US20240190890, Compound I-263::(R)-3-(5-((2-oxa-6-azaspiro[3.3]heptan-6-yl)methyl)-2-vinylpyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 47.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689037&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430138 504490701 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433854 C\C=C\c1cc(c(C)cn1)-c1ccc2c3c4NC[C@@H](C)NC(=O)c4sc3ccc2n1 InChI=1S/C24H22N4OS/c1-4-5-15-10-17(13(2)11-25-15)19-7-6-16-18(28-19)8-9-20-21(16)22-23(30-20)24(29)27-14(3)12-26-22/h4-11,14,26H,12H2,1-3H3,(H,27,29) ATSXBIDTBWEJTA-UHFFFAOYSA-N 689038 US20240190890, Compound I-265::(R,E)-10-methyl-3-(5-methyl-2-(prop-1-en-1-yl)pyridin-4-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 210 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689038&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430139 504490702 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433855 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2cc(CC#N)ncc2C)C(=O)N1 InChI=1S/C23H19N5OS/c1-12-10-25-14(7-8-24)9-16(12)18-4-3-15-17(28-18)5-6-19-20(15)21-22(30-19)23(29)27-13(2)11-26-21/h3-6,9-10,13,26H,7,11H2,1-2H3,(H,27,29) YLUGJWFTMUUAFR-UHFFFAOYSA-N 689039 US20240190890, Compound I-267::(R)-2-(5-methyl-4-(10-methyl-8-oxo-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-3-yl)pyridin-2-yl)acetonitrile MAP kinase-activated protein kinase 2 Homo sapiens 1000 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689039&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430140 504490703 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433856 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2ccnc(Cl)c2)C(=O)N1 InChI=1S/C20H15ClN4OS/c1-10-9-23-18-17-12-2-3-13(11-6-7-22-16(21)8-11)25-14(12)4-5-15(17)27-19(18)20(26)24-10/h2-8,10,23H,9H2,1H3,(H,24,26) DXASXHJWKHLFQP-UHFFFAOYSA-N 689040 US20240190890, Compound I-272::(R)-3-(2-chloropyridin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 68.0 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689040&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542360 504490704 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433857 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)ncc2F)C(=O)N1 InChI=1S/C19H13ClFN5OS/c1-8-6-22-16-14-9-2-3-12(15-10(21)7-23-19(20)26-15)25-11(9)4-5-13(14)28-17(16)18(27)24-8/h2-5,7-8,22H,6H2,1H3,(H,24,27) CGVUZGKBSROPDO-UHFFFAOYSA-N 689041 US20240190890, Compound I-273::(R)-3-(2-chloro-5-fluoropyrimidin-4-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 153 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689041&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171542171 504490705 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6 1433858 C[C@@H]1CNc2c(sc3ccc4nc(ccc4c23)-c2nc(Cl)c(cc2F)C(F)(F)F)C(=O)N1 InChI=1S/C21H13ClF4N4OS/c1-8-7-27-17-15-9-2-3-13(16-11(23)6-10(19(22)30-16)21(24,25)26)29-12(9)4-5-14(15)32-18(17)20(31)28-8/h2-6,8,27H,7H2,1H3,(H,28,31) ADWBRORZUWWHKP-UHFFFAOYSA-N 689042 US20240190890, Compound I-274::(R)-3-(6-chloro-3-fluoro-5-(trifluoromethyl)pyridin-2-yl)-10-methyl-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one MAP kinase-activated protein kinase 2 Homo sapiens 752 US Patent 10.7270/Q2VX0MTW aid1964046 US20240190890 Hu, X; Qiao, L; Seletsky, B; Patton, M; Cao, M; van der Mei, F; Miao, G; McDonald, I; Dzierba, C 6/13/2024 11/8/2024 Bristol-Myers Squibb http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=689042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3678&target=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=689042&enzyme=MAP+kinase-activated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 172430141 504490706 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH 2ONL,1NY3,1NXK,1KWP,6TCA,2OZA,4TYH,7NRY,3FYK,3FYJ,2P3G,2JBP,2JBO,3GOK,3WI6,3KC3,3FPM,3A2C,2PZY,3R30,3R2Y,3R2B MAP kinase-activated protein kinase 2 MAPK2_HUMAN P49137 Q5SY30 Q5SY41 Q8IYD6